2024년도 연구현황

2024

• 2024
• 2023
• 2022
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010
• 2009
• 2008
• 2007

국내학술지 연구논문

호흡기내과

• Kim HJ. Nonpharmacological Treatment for Nontuberculous Mycobacterial Pulmonary Disease. 2024 Oct;87(4):451-457.
• Gu KM, Jung JW, Kang MJ, Kim DK, Choi H, Cho YJ, Jang SH, Lee CH, Oh YM, Park JS, Kim JY. Eosinophilia Is a Favorable Marker for Pneumonia in Chronic Obstructive Pulmonary Disease. 2024 Oct;87(4):465-472. doi: 10.4046/trd.2023.0174. Epub 2024 May 3.
• Kwak N, Kim JY, Kim HJ, Kwon BS, Lee JH, Mok J, Kwon YS, Kang YA, Park Y, Lee JY, Jeon D, Lee JK, Yang JS, Whang J, Kim KJ, Kim YR, Cheon M, Park J, Hahn S, Yim JJ. High-Dose Rifampicin for 3 Months after Culture Conversion for Drug-Susceptible Pulmonary Tuberculosis. 2025 Jan;88(1):170-180. doi: 10.4046/trd.2024.0099. Epub 2024 Sep 27.

순환기내과

• Jin Joo Park. The Next Chapter of International Journal of Heart Failure. Int J Heart Fail. 2024 Oct 21;6(4):159-160.
• Nan Young Bae, Tae-Min Rhee, Chan Soon Park, You-Jung Choi, Hyun-Jung Lee, Hong-Mi Choi, Jun-Bean Park, Yeonyee E Yoon, Yong-Jin Kim, Goo-Yeong Cho, In-Chang Hwang, Hyung-Kwan Kim. Mildly Reduced Renal Function Is Associated With Increased Heart Failure Admissions in Patients With Hypertrophic Cardiomyopathy. Journal of Korean Medical Science. 2024 Mar 4;39(8):e80.
• Yoon M, Kim EJ, Han SW, Park SM, Kim IC, Cho MC, Ahn HS, Shin MS, Hwang SJ, Jeong JO, Yang DH, Kim JJ, Choi JO, Cho HJ, Yoo BS, Kang SM, Choi DJ. The Third Nationwide Korean Heart Failure III Registry (KorHF III): The Study Design Paper. Int J Heart Fail. 2024 Apr 1;6(2):70-75.
• Hwang IC, Kim CH, Kim JY, Park J, Choi HJ, Choi HM, Yoon YE, Cho GY. Changes in Risk Factor Status and Risk of Future ASCVD Events in Primary Prevention. Korean Circulation Journal. 2024 Jun;54(6):354-356.
• Ahn H, Lim HE, On YK, Selma JM, Kueffer FJ, van Bragt KA, Obidigbo V, Oh IY. Long-term Outcome of Cryoballoon Ablation in Korean Patients With Atrial Fibrillation: Real-World Experience From the Cryo Global Registry. Korean Circ J. 2024 Oct;54(10):619-633.
• Jang Y, Choi H, Yoon YE, Jeon J, Kim H, Kim J, Jeong D, Ha S, Hong Y, Lee SA, Park J, Choi W, Choi HM, Hwang IC, Cho GY, Chang HJ. An Artificial Intelligence-Based Automated Echocardiographic Analysis: Enhancing Efficiency and Prognostic Evaluation in Patients With Revascularized STEMI. Korean Circ J. 2024 Nov;54(11):743-756.
• Kim HM, Kim HL, Kim MA, Lee HY, Park JJ, Choi DJ; on the behalf of the KorAHF Investigators. Sex differences in clinical characteristics and long-term outcome in patients with heart failure: data from the KorAHF registry. Korean J Intern Med. 2024 Jan;39(1):95-109.
• Kim ES, Park SK, Youn JC, Lee HS, Lee HY, Cho HJ, Choi JO, Jeon ES, Lee SE, Kim MS, Kim JJ, Hwang KK, Cho MC, Chae SC, Kang SM, Park JJ, Choi DJ, Yoo BS, Cho JY, Kim KH, Oh BH, Greenberg B, Baek SH. Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea. J Korean Med Sci. 2024 Jan 8;39(1):e8.
• Lee SH, Hong WP, Kim J, Cho Y, Lee E. Smartphone AI vs. Medical Experts: A Comparative Study in Prehospital STEMI Diagnosis. Yonsei Medical Journal. 2024 Mar;65(3):174-180.
• Lee JH, Youn YJ, Jeon HS, Lee JW, Ahn SG, Yoon J, Gwon HC, Song YB, Choi KH, Kim HS, Chun WJ, Hur SH, Nam CW, Cho YK, Han SH, Rha SW, Chae IH, Jeong JO, Heo JH, Lim DS, Park JS, Hong MK, Doh JH, Cha KS, Kim DI, Lee SY, Chang K, Hwang BH, Choi SY, Jeong MH, Lee HJ. Transradial Versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stent. J Korean Med Sci. 2024 Mar 18;39(10):e111.
• Lee CJ, Lee H, Yoon M, Chun KH, Kong MG, Jung MH, Kim IC, Cho JY, Kang J, Park JJ, Kim HC, Choi DJ, Lee J, Kang SM. Heart Failure Statistics 2024 Update: A Report From the Korean Society of Heart Failure. Int J Heart Fail. 2024 Apr 18;6(2):56-69.
• Eun-Bi Jeon, Nayoung Kim, Beom Joon Kim, In-Chang Hwang, Sang Bin Kim, Ji-Hyun Kim, Yonghoon Choi, Yu Kyung Jun, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Soyeon Ahn. Risk of Ischemic Stroke in Relation to Helicobacter pylori Infection and Eradication Status: A Large-Scale Prospective Observational Cohort Study. Gut and Liver. 2024 Jul 15;18(4):642-653.
• Kim D, Choi JO, Cho YH, Sung K, Oh J, Cho HJ, Jung SH, Lee HY, Park JJ, Choi DJ, Kang SM, Kim MS, Kim JJ. Impacts of Pre-transplant Panel-Reactive Antibody on Post-transplantation Outcomes: A Study of Nationwide Heart Transplant Registry Data. Korean Circ J. 2024 Jun;54(6):325-335.
• Lee PH, Kim JS, Song JK, Kwon SU, Kim BJ, Lee JS, Sun BJ, Woo JS, Ann SH, Suh JW, Kim JY, Lee K, Lee SY, Heo R, Jeong S, Jang JY, Bae JW, Kim YD, Heo SH, Kim JS. Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale. J Stroke. 2024 May;26(2):242-251.
• Choi YJ, Park CS, Rhee TM, Lee HJ, Choi HM, Hwang IC, Park JB, Yoon YE, Na JO, Kim HK, Kim YJ, Cho GY, Sohn DW, Lee SP. Mitral Annular Tissue Velocity Predicts Survival in Patients With Primary Mitral Regurgitation. Korean Circ J. 2024 Jun;54(6):311-322.
• Choi HI, Lee SE, Hyun J, Kim D, Choi DJ, Jeon ES, Lee HY, Cho HJ, Kim H, Kim IC, Oh J, Yoon M, Park JJ, Choi JO, Ju MH, Kang SM, Lee SY, Jung SH, Kim JJ. The Korean Organ Transplant Registry (KOTRY): Third Official Adult Heart Transplant Report. Korean Circ J. 2025 Feb;55(2):79-96.
• Kim HK, Ryoo S, Lee SH, Hwang D, Choi KH, Park J, Lee HJ, Yoon CH, Lee JH, Hahn JY, Hong YJ, Hwang JY, Jeong MH, Park DA, Nam CW, Kim W. 2024 Korean Society of Myocardial Infarction/National Evidence-Based Healthcare Collaborating Agency Guideline for the Pharmacotherapy of Acute Coronary Syndromes. Korean Circ J. 2024 Dec;54(12):767-793.
• Park JH, Kim M, Park JJ, Park JB, Cho GY. Prognostic Role of RVGLS/PASP Ratio, a New Echocardiographic Parameter of the Right Ventricle-Pulmonary Artery Coupling, in Patients With Acute Heart Failure. Int J Heart Fail. 2024 Oct 28;6(4):165-173.
• Choi YJ, Park CS, Rhee TM, Lee HJ, Choi HM, Hwang IC, Park JB, Yoon YE, Na JO, Kim HK, Kim YJ, Cho GY, Sohn DW, Lee SP. Mitral Annular Tissue Velocity Predicts Survival in Patients With Primary Mitral Regurgitation. Korean Circ J. 2024 Jun;54(6):311-322.

소화기내과

• Song DH, Kim N, Jo HH, Kim S, Choi Y, Oh HJ, Lee HS, Yoon H, Shin CM, Park YS, Lee DH, Kang SH, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Ahn S, Surh YJ. Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients. Gut Liver. 2024 Mar 15;18(2):231-244.
• Oh J, Choi GH, Chang Y, Kim J, Park K, Yeom H, Seo S, Gwack J, Jeong SH. A Silent Outbreak of Hepatitis E Virus (HEV) Infection or False-Positive Reaction of Anti-HEV IgM after COVID-19 Vaccination? Epidemiological Investigation of an Outbreak in a Korean Factory Complex in 2022. Gut Liver. 2024 May 15;18(3):531-538.
• Song CH, Kim N, Nam RH, Choi SI, Jang JY, Kim EH, Choi J, Choi Y, Yoon H, Lee SM, Seok YJ. The Possible Preventative Role of Lactate- and Butyrate-Producing Bacteria in Colorectal Carcinogenesis. Gut Liver. 2024 Jul 15;18(4):654-666.
• Chang YH, Choi YJ, Shin CM, Moon JS, Kim TY, Yoon H, Park YS, Kim N, Lee DH. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. J Neurogastroenterol Motil. 2024 Jan 30;30(1):73-86.
• Jun YK, Kim N, Yoon H, Park JH, Kim HK, Choi Y, Lee JA, Shin CM, Park YS, Lee DH. Molecular Activity of Inflammation and Epithelial-Mesenchymal Transition in the Microenvironment of Ulcerative Colitis. Gut Liver. 2024 Nov 15;18(6):1037-1047.
• Kim HJ, Kim N, Jang JY, Kim S, Lee J, Oh HJ. Influence of Cytokine Genetic Polymorphisms in Helicobacter pylori-Associated Gastric Inflammation According to Sex in South Korea. Gut Liver. 2024 Nov 15;18(6):1002-1013.
• Jang ES, Choi HY, Ki M, Kim BH, Kim KA, Jeong SH. Prevalence, Incidence, and Treatment Pattern of Wilson's Disease Using National Health Insurance Data From 2010-2020, Korea. J Korean Med Sci. 2024 Apr 1;39(12):e115.
• Choi SI, Kim N, Choi Y, Nam RH, Jang JY, Cho SY. The Effect of Clostridium butyricum on Gut Microbial Changes and Functional Profiles of Metabolism in High-fat Diet-fed Rats Depending on Age and Sex. J Neurogastroenterol Motil. 2024 Apr 30;30(2):236-250.
• Jeon EB, Kim N, Kim BJ, Hwang IC, Kim SB, Kim JH, Choi Y, Jun YK, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Risk of Ischemic Stroke in Relation to Helicobacter pylori Infection and Eradication Status: A Large-Scale Prospective Observational Cohort Study. Gut Liver. 2024 Jul 15;18(4):642-653.
• Shin CM. Can Epigenetic and Gastric Microbiome Markers Predict the Risk of Helicobacter pylori-Negative Gastric Cancer? Gut Liver. 2024 Jul 15;18(4):553-555.
• Jun YK, Yoon H. [Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators]. Korean J Gastroenterol. 2024 Aug 25;84(2):51-64. Korean.
• Jo H, Ahn S, Ohn JH, Shin CM, Ji E, Kim D, Jung SJ, Lee J. Insulin Resistance and Impaired Insulin Secretion Predict Incident Diabetes: A Statistical Matching Application to the Two Korean Nationwide, Population-Representative Cohorts. Endocrinol Metab (Seoul). 2024 Oct;39(5):711-721.
• Choi Y, Jang J, Kim N. Effect of body mass index on gastric cancer risk according to sex in Korea: a nationwide cohort study and literature review. Ewha Med J. 2024 Apr;47(2):e19.
• Jung JH, Won SH, Jung K, Lee JS, Lee JC, Kim JW, Yoon YS, Hwang JH, Han HS, Kim J. Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. Gut Liver. 2024 Jul 15;18(4):737-746.
• Kim JH, Jung HY, Yoo IK, Park SY, Kim JG, Sung JK, Jang JS, Cheon GJ, Kim KO, Kim TO, Lee ST, Cho KB, Chun HJ, Park JJ, Park MI, Jang JY, Jeon SW, Cho JW, Kang DH, Kim GH, Kim JJ, Kim SG, Kim N, Lee YC, Hong SJ, Kim HS, Lee S, Lee SW. Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study. Gut Liver. 2024 Jan 15;18(1):70-76.
• Yoon J, Hong SW, Han KD, Lee SW, Shin CM, Park YS, Kim N, Lee DH, Kim JS, Yoon H. Risk Factors of Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study. Gut Liver. 2024 May 15;18(3):489-497.
• Tae CH, Cha RR, Oh JH, Gweon TG, Park JK, Bang KB, Song KH, Huh CW, Lee JY, Shin CM, Kim JW, Youn YH, Kwon JG; Functional Dyspepsia Research Group under the Korean Society of Neurogastroenterology and Motility. Clinical Trial: Efficacy of Mosapride Controlled-release and Nortriptyline in Patients With Functional Dyspepsia: A Multicenter, Double-placebo, Double-blinded, Randomized Controlled, Parallel Clinical Study. J Neurogastroenterol Motil. 2024 Jan 30;30(1):106-115.
• Huh CW, Youn YH, Jung DH, Cha RR, Kim YJ, Jung K, Song KH, Bang KB, Tae CH, Choi SI, Shin CM; Functional Dyspepsia Research Group Under the Korean Society of Neurogastroenterology and Motility. Efficacy of Tegoprazan in Patients With Functional Dyspepsia: A Prospective, Multicenter, Single-arm Study. J Neurogastroenterol Motil. 2024 Jul 30;30(3):313-321.
• Kang SJ, Tae CH, Bang CS, Shin CM, Jeong YH, Choi M, Hwang JH, Saito Y, Chiu PWY, Rerknimitr R, Khor C, Khien VV, Choi KD, Shim KN, Song GA, Lee OY; Korean Society of Gastrointestinal Endoscopy Task Force on Clinical Practice Guidelines. International Digestive Endoscopy Network Consensus on the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy. Gut Liver. 2024 Sep 15;18(5):764-780.
• Kim S, Jun YK, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Yoon H. Trends and Factors Related to Quality of Life in Patients with Inflammatory Bowel Disease. Gut Liver. 2025 Mar 15;19(2):236-242.
• Kim HJ, Yoon H, Lee JW. [Efficacy of Second Forward-View Colonoscopy to Improve Adenoma Detection of Right-Side Colon: Systematic Review and Meta-Analysis]. Korean J Gastroenterol. 2024 Dec 25;84(6):265-273.
• Cho JH, Kim J, Lee HS, Ryu SJ, Jang SI, Kim EJ, Kang H, Lee SS, Song TJ, Bang S. Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions. Gut Liver. 2024 Jan 15;18(1):184-191.

혈액종양내과

• Lee JY, Lee JH, Seo J, Kang M, Jung EH, Kim SA, Suh KJ, Kim JW, Kim SH, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Lee JS, Bang SM. Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study. J Korean Med Sci. 2024 Jun 10;39(22):e175.
• Hwang HG, Lee JH, Kim SA, Kim YK, Kim MS, Hong J, Yhim HY, Bang SM. Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence. J Korean Med Sci. 2024 Sep 23;39(36):e252.
• Lee SE, Hong J, Bang SM, Park J, Choi CW, Bae SH, Kim MK, Yoon SY, Kim SY. Differences in Clinical Outcomes Between Hydroxyurea-Resistant and –Intolerant Polycythemia Vera Patients. J Korean Med Sci. 2024 Jan 22;39(3):e24.
• Kook HW, Jang JE, Min CK, Yoon DH, Kim K, Bang SM, Park Y, Lee JH, Yoon SS, Kim JS. A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. J Korean Med Sci. 2024 Jan 15;39(2):e5.

내분비내과

• Kong SH, Park JY, Shin MK, Lee HJ, Kim JW, Park SS, Kim SW, Shin CS, Song TJ. Effectiveness of Bisphosphonates in Young Adults with Fragility Fractures: Representative Population-Based Cohort Study. J Clin Endocrinol Metab. 2024 Dec.
• Kong SH, Jo AJ, Park CM, Park KI, Yun JE, Kim JH. Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study. Endocrinol Metab (Seoul). 2024 Aug 30. doi: 10.3803/EnM.2024.1990. Epub ahead of print. PMID: 39212038.
• Park SY, Kong SH, Kim KJ, Ahn SH, Hong N, Ha J, Lee S, Choi HS, Baek KH, Kim JE, Kim SW. Effects of Endocrine-Disrupting Chemicals on Bone Health. Endocrinol Metab (Seoul). 2024 Aug;39(4):539-551. doi: 10.3803/EnM.2024.1963. Epub 2024 Jul 17. PMID: 39015028; PMCID: PMC11375301.
• Kong SH. Insights from Decades of Supplementing Calcium and Vitamin D. Endocrinol Metab (Seoul). 2024 Jun;39(3):445-447. doi: 10.3803/EnM.2024.2016. Epub 2024 May 23. PMID: 38778478; PMCID: PMC11220217.
• Kong SH, Bae JM, Kim JH, Kim SW, Han D, Shin CS. Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality. Endocrinol Metab (Seoul). 2024 Apr;39(2):375-386. doi: 10.3803/EnM.2023.1827. Epub 2024 Mar 21. PMID: 38509667; PMCID: PMC11066450.
• Kim MJ, Moon JH, Lee EK, et al. Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines. Endocrinol Metab (Seoul). 2024;39(1):47-60. DOI: 10.3803/EnM.2024.1937.
• Son H, Moon JH, Choi SH, Cho NH, Kwak SH, Jang HC. Amelioration of Insulin Resistance After Delivery Is Associated With Reduced Risk of Postpartum Type 2 Diabetes in Women with Gestational Diabetes Mellitus. Endocrinol Metab (Seoul). 2024;39(5):701-710.
• Lee J, Moon JH. Targeting Cardiac Fibrosis in Diabetic Heart Failure: The Role of EZH2, AMPK, and PPAR-γ Pathways, Diabetes Metab J, 2024;48(6):1176-1178
• Kim HA, Jang HN, Kong SH, Lee Y, Choi SH, Cho YM, Jang HC, Oh TJ. Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment. Endocrinol Metab (Seoul). 2024 Aug;39(4):653-658. doi: 10.3803/EnM.2024.1919. Epub 2024 May 16 PMID: 38752266
• 오오태정. GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로 J Korean Diabetes. 2024;25(2):76-81.
• Park YH, Sohn M, Lee SY, Lim S. Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients. Diabetes Metab J. 2024 Mar;48(2):253-264. PMID: 3827379
• Son JW, Lim S. Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management. Endocrinol Metab (Seoul). 2024 Apr;39(2):206-221. PMID: 38626909
• Park YH, Sohn M, Lim S. Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64). Diabetes Metab J. 2024 Sep;48(5):1012-1013. PMID: 39313235
• Joon Ho Moon; Sookyung Won; Hojeong Won; Heejun Son; Tae Jung Oh; Soo Heon Kwak; Sung Hee Choi; Hak Chul Jang, Metabolic Phenotypes of Women with Gestational Diabetes Mellitus Affect the Risk of Adverse Pregnancy Outcomes, EnM November 28, 2024
• Baek SK, Lee SH, Park SS, Ahn CH, Kong SH, Kim WW, Lee YM, Kim SJ, Song DE, Sung TY, Lee KE, Kim JH, Jung KC, Koh JM. The Modified S-GRAS Scoring System for Prognosis in Korean with Adrenocortical Carcinoma. Endocrinol Metab (Seoul). 2024 Oct;39(5):803-812. doi: 10.3803/EnM.2024.2086. Epub 2024 Sep 25. PMID: 39322187; PMCID: PMC11525693.
• Kim HA, Jang HN, Kong SH, Lee Y, Choi SH, Cho YM, Jang HC, Oh TJ. Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment. Endocrinol Metab (Seoul). 2024 Aug;39(4):653-658. doi: 10.3803/EnM.2024.1919. Epub 2024 May 16. PMID: 38752266; PMCID: PMC11375305.
• Kim KJ, Ha J, Kim SW, Kim JE, Lee S, Choi HS, Hong N, Kong SH, Ahn SH, Park SY, Baek KH. Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations. Endocrinol Metab (Seoul). 2024 Apr;39(2):267-282. doi: 10.3803/EnM.2024.1939. Epub 2024 Apr 25. PMID: 38693817; PMCID: PMC11066446.
• Moon JS, Kang S, Choi JH, Lee KA, Moon JH, et al. 2023 Clinical Practice Guidelines for Diabetes Mellitus in Korea: Full version recommendation of the Korean Diabetes Association, Diabetes Metab J, 2024;48(4):546-708
• Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, Lim JH, Song YJ, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Bae J, Jeon E, Kim JM, Kang SM, Park JH, Yun JS, Cha BS, Moon MK, Lee BW. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association. Diabetes Metab J. 2024 Jul;48(4):546-708. doi: 10.4093/dmj.2024.0249. Epub 2024 Jul 26. PMID: 39091005
• Kim, M. J. et al. Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines. Endocrinol. Metab. 39, 47–60 (2024).
• Park JY, Lee J, Choi YH, Min KW, Han KA, Ahn KJ, Lim S, Kim YH, Ahn CW, Choi KM, Yoon KH; Practical Evidence of Antidiabetic Combination Therapy in Korea (PEAK) study investigators. Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial. Diabetes Metab J. 2024;48(5):915-928. PMID: 38650099
• Lee JE, Yu SH, Kim SR, Ahn KJ, Song KH, Lee IK, Shon HS, Kim IJ, Lim S, Kim DM, Chung CH, Lee WY, Lee SH, Kim DJ, Cho SR, Jung CH, Jeon HJ, Lee SH, Park KY, Rhee SY, Kim SG, Park SO, Kim DJ, Kim BJ, Lee SA, Kim YH, Kim KS, Seo JA, Nam-Goong IS, Lee CW, Kim DK, Kim SW, Cho CG, Kim JH, Kim YJ, Yoo JM, Min KW, Lee MK. Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial. Diabetes Metab J. 2024 Jul;48(4):730-739. PMID: 38763510
• Kim NH, Lee J, Chon S, Yu JM, Jeong IK, Lim S, Kim WJ, Song K, Cho HC, Yu HM, Kim KA, Kim SS, Lee SH, Kim CH, Kwak SH, Lee YH, Chung CH, Lee S, Jin HY, Lee JH, Koh G, Kim SY, Kim J, Lee JH, Kim TN, Jeon HJ, Lee JH, Jeon JH, Yoo HJ, Kim HK, Park HK, Nam-Goong IS, Hong S, Ahn CW, Yu JH, Park JH, Park KG, Park CH, Joung KH, Ryu OH, Park KY, Hong EG, Cha BS, Won KC, Chung YS, Kim SG. Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE). Endocrinol Metab (Seoul). 2024 Oct;39(5):722-731. PMID: 39174014
• Kim HA, Jang HN, Kong SH, Lee Y, Choi SH, Cho YM, Jang HC, Oh TJ. Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment. Endocrinol Metab (Seoul). 2024 Aug;39(4):653-658. doi: 10.3803/EnM.2024.1919. Epub 2024 May 16 PMID: 38752266
• Son H, Moon JH, Choi SH, Cho NH, Kwak SH, Jang HC. Amelioration of Insulin Resistance after Delivery Is Associated with Reduced Risk of Postpartum Diabetesin Women with Gestational Diabetes Mellitus. Endocrinol Metab (Seoul). 2024Oct;39(5):701-710. doi: 10.3803/EnM.2024.1974. Epub 2024 Aug 21. PMID: 39165178;PMCID: PMC11525696.

신장내과

• Cho JM, Cha RH, Kim DK, Chin HJ. Performance evaluation of Chronic Kidney Disease Epidemiology Collaboration equations for estimated glomerular filtration rate compared to inulin clearance in Koreans. Kidney Res Clin Pract. 2024 Feb 7. doi: 10.23876/j.krcp.23.124. Epub ahead of print. PMID: 38325868.
• Choi JY, Chin HJ, Lee H, Jeon Y, Lim JH, Jung HY, Cho JH, Kim CD, Kim YL, Park SH. Effect of immunosuppressive agents on clinical outcomes in idiopathic membranous nephropathy. Kidney Res Clin Pract. 2024 Sep;43(5):635-647. doi: 10.23876/j.krcp.22.255. Epub 2023 Sep 8. PMID: 37798848; PMCID: PMC11467357.
• Hong WK, Kim S, Gong HS. Fracture Management in Chronic Kidney Disease: Challenges and Considerations for Orthopedic Surgeons. Clin Orthop Surg. 2024 Apr;16(2):173-183. doi: 10.4055/cios23244. Epub 2024 Mar 15. PMID: 38562627; PMCID: PMC10973623.
• Kim JH, Lee YH, Kim DK, Kim JS, Jeong KH, Chung KY, Jeong JC, Choi SJN, Yang J, Kim MS, Hwang HS; Korean Organ Transplantation Registry Study Group. Comparisons of clinical outcomes between hypertensive and normotensive living kidney donors: a prospective, multicenter nationwide cohort study. Kidney Res Clin Pract. 2024 Aug 21. doi: 10.23876/j.krcp.23.283. Epub ahead of print. PMID: 39164853.
• Kim TB, Ahn SY, Oh J, Bae EH, Chin HJ, Kim MG, Jo SK, Cho WY, Oh SW. The Impact of Obesity on Kidney Disease: Observational Cohort Study Analyzing 14,492 Kidney Biopsy Cases. J Korean Med Sci. 2024 Jan 22;39(3):e12. doi: 10.3346/jkms.2024.39.e12. PMID: 38258359; PMCID: PMC10803208.
• Makmun A, Satirapoj B, Tuyen DG, Foo MWY, Danguilan R, Gulati S, Kim S, Bavanandan S, Chiu YW, Tang SCW. The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions. Kidney Res Clin Pract. 2024 Sep 9. doi: 10.23876/j.krcp.23.194. Epub ahead of print. PMID: 39384350.
• Park S, Kim Y, Baek CH, Cho H, Park JI, Koh ES, Lee JP, Park SH, Kim HW, Han SH, Chin HJ, Kim DK, Moon KC, Kim YG, Lee H. Conventional machine learning-based prediction models did not outperform the International IgA Nephropathy Prediction Tool. Kidney Res Clin Pract. 2024 Sep 12. doi: 10.23876/j.krcp.23.212. Epub ahead of print. PMID: 39384361.
• Park YW, Hwang J, Kim M, Kim SM, Jeong Y, Kang M, Kang E, Ryu H, Park SK, Kim Y, Jeong JC, Han SH, Oh KH. Hospitalization among adults with chronic kidney disease: results from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD) study. Kidney Res Clin Pract. 2024 Jul 25. doi: 10.23876/j.krcp.23.263. Epub ahead of print. PMID: 39109401.
• Ryu JY, Yun G, Kwon EJ, Son HE, Kim K, Lee SH, Kang KP, Kwon YJ, Chin HJ; Korean GlomeruloNEphritis sTudy (KoGNET) Group. Characteristics of glomerulonephritis with dominant C1q precipitation compared to corresponding glomerulonephritis without C1q staining on immunofluorescent examination. Kidney Res Clin Pract. 2024 Nov 20. doi: 10.23876/j.krcp.23.238. Epub ahead of print. PMID: 39639420.
• Yun D, Han SS, Lee J, Kim Y, Kim K, Jin K, Kim JE, Ahn SY, Ko GJ, Park S, Kim S, Jung HY, Cho JH, Park SH, Koh ES, Chung S, Lee JP, Kim DK, Kim SG, An JN; LINKA investigators. Study protocol for a consortium linking health medical records, biospecimens, and biosignals in Korean patients with acute kidney injury (LINKA cohort). Kidney Res Clin Pract. 2024 Nov 11. doi: 10.23876/j.krcp.24.061. Epub ahead of print. PMID: 39523797.
• Yun G, Kwon EJ, Park S, Jeong JC, Kim S, Na KY, Chin HJ. Comparison between characteristics of immunoglobulin M nephropathy and other glomerular diseases. Kidney Res Clin Pract. 2025 Jan;44(1):79-90. doi: 10.23876/j.krcp.23.159. Epub 2024 Feb 15. PMID: 38389153; PMCID: PMC11838854.
• Han S, Kim S. A New Era in Diabetic Kidney Disease Treatment: The Four Pillars and Strategies to Build Beyond. Electrolyte Blood Press. 2024 Dec;22(2):21-28. doi: 10.5049/EBP.2024.22.2.21. Epub 2024 Dec 30. PMID: 39780853; PMCID: PMC11704317.
• Jang SY, Hwang SH, Choi Y, Kim WY, Park SH, Kim WM, Kwon EJ, Kim S. Evaluation of the novel ALK5 inhibitor EW-7197 on therapeutic efficacy in renal fibrosis using a three-dimensional chip model. Kidney Res Clin Pract. 2024 Sep 9. doi: 10.23876/j.krcp.23.324. Epub ahead of print. PMID: 39384357.
• Yun G, Kim T, Kim KS, Shin K, Paik JH, Park JY, Lee LP, Hong JW, Kim S. A noninvasive method of diagnosing membranous nephropathy using exosomes derived from urine. Kidney Res Clin Pract. 2024 Sep 26. doi: 10.23876/j.krcp.23.208. Epub ahead of print. PMID: 39384351.

알레르기내과

• Kim HJ, Shim JS, Park GY, Kang DY, Shin JY, Kim SM, Kim SH, Lee J, Nam YH, Choi GS, Kang MG, Sim DW, Kim MH, Kim MS, Ye YM, Jung CG, Yang MS, Kim S, Jeong YY, Lee SE, Park HK, Sohn KH, Yun J, Kang HR. Association of HLA-B∗13:01 with DRESS and HLA-A∗31:01 with eosinophilia in SJS/TEN induced by carbamazepine. J Allergy Clin Immunol Pract. 2024 Dec;12(12):3436-3438.e3. doi: 10.1016/j.jaip.2024.08.039. Epub 2024 Aug 27. PMID: 39197748.
• An J, Lee CE, Kim SY, Park SY, Kim S, Sim DW, Yang MS, Park HK, Kim SH, Kim SH, Ye YM, Lee JH, Hur GY, Park HK, Koh Y, Park JW, Lee J, Lee BJ, Kim TB. Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis. Allergy Asthma Immunol Res. 2024 May;16(3):308-316. doi: 10.4168/aair.2024.16.3.308. PMID: 38910288; PMCID: PMC11199152.
• Jun H, Park JY, Oh JY, Won HK, Kang SY, Park SY, Kim BK, Kim MY, Kim YC, Lee HY, Jo EJ, Lee SE, Kim SH, Kim SH, Chang YS, Kim SH, Lee BJ, Chung KF, Song WJ; Korean Chronic Cough Registry Investigators. Exploring Traits Associated With Central Sensitization Features in Patients With Chronic Cough. Allergy Asthma Immunol Res. 2024 Nov;16(6):690-700. doi: 10.4168/aair.2024.16.6.690. PMID: 39622692; PMCID: PMC11621473.
• Kim SH. Biologics in Severe Asthma: An Ideal Choice for Achieving Control. Allergy Asthma Immunol Res. 2024 May;16(3):214-216. doi: 10.4168/aair.2024.16.3.214. PMID: 38910280; PMCID: PMC11199158.
• Park SY, Fowler S, Shaw DE, Adcock IM, Sousa AR, Djukanovic R, Dahlen SE, Sterk PJ, Kermani NZ, Calhoun W, Israel E, Castro M, Mauger D, Meyers D, Bleecker E, Moore W, Busse W, Jarjour N, Denlinger L, Levy B, Choi BH, Kim SH, Jang AS, Lee T, Cho YJ, Shin YS, Cho SH, Won S, Cruz AA, Wenzel SE, Chung KF, Kim TB. Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents. Allergy Asthma Immunol Res. 2024 Jul;16(4):338-352. doi: 10.4168/aair.2024.16.4.338. PMID: 39155735; PMCID: PMC11331196.
• Shim JS, Kim SY, Kim SH, Lee T, Jang AS, Park CS, Jung JW, Kwon JW, Kim MY, Yoon SY, Lee J, Choi JH, Shin YS, Kim HK, Kim S, Kim JH, Lee SY, Nam YH, Kim SH, Park SY, Kim BK, Kim SH, Park HK, Jin HJ, Kim SR, Yoon HJ, Park HK, Cho YJ, Kim MH, Kim TB; Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) Investigators. Clinical Characteristics of T2-Low and T2-High Asthma-Chronic Obstructive Pulmonary Disease Overlap: Findings From COREA Cohort. Allergy Asthma Immunol Res. 2024 Nov;16(6):601-612. doi: 10.4168/aair.2024.16.6.601. PMID: 39622685; PMCID: PMC11621477.

감염내과

• Moon SM, Kim HB. Benchmarking Antimicrobial Drug Use: Opportunitiesand Challenges. Infect Chemother. 2024 Jun;56(2):276-277. doi: 10.3947/ic.2024.0063. PubMed PMID: 38960741; PubMed Central PMCID: PMC11224038.
• Moon SM, Kim B, Kim HB. Quantitative and qualitative evaluationof antimicrobial usage: the first step for antimicrobial stewardship. Korean J Intern Med. 2024 May;39(3):383-398. doi: 10.3904/kjim.2023.506. Epub 2024 Apr 30. PubMed PMID: 38715229; PubMed Central PMCID: PMC11076899.
• Park JW, Kim YK, Park YS, Kim HB, Choi JY, Choi HJ, Kim CJ, Park JS, Lee SW, Kim YC, Choi SJ, Jung JT, Park SY, Han SH, Kim SY, Kim SH, Son HJ, Cho MH, Youn BH, Yeon JH, Song KH. National Surgical Site Infection Surveillance System Results Report: July 2021 through June 2022.Korean J healthc assoc Infect Control Prev 2024;29(1):48-58. doi: 10.14192/kjicp.2024.29.1.48
• Lim SY, Jo HJ, Lee SYeon, Ahn MYI, Kim YJ, Jeon JH, Kim ES, Choi JP, Kim NJ. Clinical Features of Mpox Patients in Korea: A Multicenter Retrospective Study. J Korean Med Sci. 2024 Jan 29;39(4):e19. doi: 10.3346/jkms.2024.39.e19. PMID: 38288533
• Kim JE, Myung RM, Kim BY, Kim JY, Kim T, Lee MS, Kim UJ, Park DW, Kim YS, Lee CS, Kim E S, Lee SH, Chang HH, Lee SS, Park SY, Choi HJ, Kim HI, Ha YE, Wi YM, Choi SI , Shin SY, Pai HJ. Incidence of Clostridioides difficile Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service (Incidence of Clostridioides difficile Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service). J Korean Medical Science v.39 no.12 2024년,pp.1–10. http://dx.doi.org/10.3346/jkms.2024.39.e118.

류마티스내과

• Kim HW, Lee YJ, Ha YJ, Lee EB, Lee YJ, Kang EH. Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency. 2024 Jul;39(4):668-679. doi: 10.3904/kjim.2023.276. Epub 2024 Feb 29.
• Ha JW, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Overlap syndrome of systemic sclerosis with antineutrophil cytoplasmic antibody-associated vasculitis according to 2022 ACR/EULAR criteria. 2024 May;39(3):524-536. doi: 10.3904/kjim.2023.189. Epub 2024 Jan 29.
• Seo MR, Yeo J, Park JW, Lee YA, Lee JH, Kang EH, Ji SM, Kwon SR, Kim SK, Kim TJ, Kim TH, Kim HW, Park MC, Shin K, Lee SH, Lee EY, Cha HS, Shim SC, Yoon Y, Lee SH, Lim JH, Baek HJ; Korean Society of Spondyloarthritis Research. Korean treatment recommendations for patients with axial spondyloarthritis. 2024 Jan;39(1):200. doi: 10.3904/kjim.2023.194.e1. Epub 2023 Nov 10.
• Yeo J, Seo MR, Park JW, Lee YA, Lee JH, Kang EH, Ji SM, Baek HJ. Literature review of non-pharmacological treatment for patients with axial spondyloarthritis. 2025 Jan;40(1):40-48. doi: 10.3904/kjim.2023.485. Epub 2024 May 27.
• Do H, Choi HJ, Choi B, Son CN, Kim SH, Ha YJ, Kim JH, Kim MJ, Shin K, Kim HO, Song R, Lee SW, Ahn JK, Lee SG, Lee CH, Son KM, Moon KW. High vegetable consumption and regular exercise are associated with better quality of life in patients with gout. 2024 Sep;39(5):845-854. doi: 10.3904/kjim.2023.476. Epub 2024 Jun 24.

노인병내과

• Choi JY, Lee HY, Lee JH, Hong Y, Park SK, Ryu DR, Lee JH, Hwang S, Kim KH, Lee SH, Kim SY, Park JH, Kim SH, Kim HL, Choi JH, Kim CH, Cho MC, Kim KI. Characteristics According to Frailty Status Among Older Korean Patients With Hypertension. J Korean Med Sci. 2024 Mar 18;39(10):e84. doi: 10.3346/jkms.2024.39.e84. PMID: 38501181; PMCID: PMC10948261.
• Lee H, Choi JY, Kim SW, Ko KP, Park YS, Kim KJ, Shin J, Kim CO, Ko MJ, Kang SJ, Kim KI. Digital Health Technology Use Among Older Adults: Exploring the Impact of Frailty on Utilization, Purpose, and Satisfaction in Korea. J Korean Med Sci. 2024 Jan 8;39(1):e7. doi: 10.3346/jkms.2024.39.e7. PMID: 38193326; PMCID: PMC10782036.

종합내과

• Hye Won Kim, Yeon Ju Lee, You-Jung Ha, Eun Bong Lee, Yun Jong Lee, Eun Ha Kang. Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency. The Korean journal of internal medicine 39 (4), 668
• Jiwon RYU, Eung-Kyu PARK, JunHyuck JANG, Dong-Hoon LEE. Clinical Validation of a Mobile-Based ACR (Urine Albumin-to-Creatinine Ratio) Test Kit: Comparative Analysis with Benchtop Devices. Korean Journal of Health Promotion 2024;24(3):118-126.

해외학술지 연구논문

호흡기내과

• Yang SH, Song MJ, Wook Kim Y, Kwon BS, Lim SY, Lee YJ, Park JS, Cho YJ, Lee JH, Lee CT, Kim HJ. Correction: Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study. 2024 Feb 13;24(1):81. doi: 10.1186/s12890-024-02881-6.
• Kim TH, Song MJ, Lim SY, Lee YJ, Cho YJ. Factors related to lung function outcomes in critically ill COVID-19 patients in South Korea. 2024 Feb;39(1):100-107. doi: 10.4266/acc.2023.00668. Epub 2024 Feb 20.
• Lim K, Lee MO, Choi J, Kim JH, Kim EM, Woo CG, Chung C, Cho YH, Hong SH, Cho YJ, Ahn SJ. Guidelines for Manufacturing and Application of Organoids: Lung. 2024 May 30;17(2):147-157. doi: 10.15283/ijsc24041. Epub 2024 May 23.
• Joo DH, Park HC, Kim JH, Yang SH, Kim TH, Kim HJ, Song MJ, Lim SY, Kim SA, Bae HW, Ahn YH, Yoon SM, Park J, Lee HY, Lee J, Lee SM, Lee JC, Cho YJ. Clinical Efficacy and Safety of an Automatic Closed-Suction System in Mechanically Ventilated Patients with Pneumonia: A Multicenter, Prospective, Randomized, Non-Inferiority, Investigator-Initiated Trial. 2024 May 21;14(11):1068. doi: 10.3390/diagnostics14111068.
• Lim SY, Park JS, Cho YJ, Lee JH, Lee CT, Lee YJ. Association of baseline muscle mass with functional outcomes in intensive care unit survivors: A single-center retrospective cohort study in Korea. 2024 Aug 9;103(32):e39156. doi: 10.
• Song MJ, Kang M, Song KH, Kim HB, Kim ES, Jung J, Lim SY. Comparison of the risk of pneumothorax in COVID-19 and seasonal influenza. 2024 Sep 10;14(1):21077.
• Kim HJ, Park S, Jeong S, Kim J, Cho YJ. Lung Organoid on a Chip: A New Ensemble Model for Preclinical Studies. 2024 Feb 28;17(1):30-37. doi: 10.
• Yang SH, Song MJ, Kim YW, Kwon BS, Lim SY, Lee YJ, Park JS, Cho YJ, Lee JH, Lee CT, Kim HJ. Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study. 2024 Jan 2;24(1):7. doi: 10.
• Kim HJ, Ko RE, Lim SY, Park S, Suh GY, Lee YJ. Sepsis Alert Systems, Mortality, and Adherence in Emergency Departments: A Systematic Review and Meta-Analysis. 2024 Jul 1;7(7):e2422823. doi: 10.
• Song MJ, Jang Y, Legrand M, Park S, Ko R, Suh GY, Oh DK, Lee SY, Park MH, Lim CM, Jung SY, Lim SY. Epidemiology of sepsis-associated acute kidney injury in critically ill patients: a multicenter, prospective, observational cohort study in South Korea. 2024 Nov 24;28(1):383.
• Ahn YH, Yoon SM, Lee J, Lee SM, Oh DK, Lee SY, Park MH, Lim CM, Lee HY; Korean Sepsis Alliance Investigators. Early Sepsis-Associated Acute Kidney Injury and Obesity. 2024 Feb 5;7(2):e2354923.
• Kim HJ, Kwak N, Yoon SH, Park N, Kim YR, Lee JH, Lee JY, Park Y, Kang YA, Kim S, Mok J, Kim JY, Jeon D, Lee JK, Yim JJ. Artificial intelligence-based radiographic extent analysis to predict tuberculosis treatment outcomes: a multicenter cohort study. 2024 Jun 7;14(1):13162. doi: 10.
• Hwang H, Kim JY, Yim JJ, Kwak N. Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatment. 2024 Jan-Dec:18:17534666241282272.
• Kim JY, Lee S, Park H, Kim HJ, Lee HW, Lee JH, Yim JJ, Kwak N, Yoon SH. Post-treatment Radiographic Severity and Mortality in Mycobacterium avium Complex Pulmonary Disease. 2024 Feb;21(2):235-242. doi: 10.
• Yang SH, Song MJ, Kim YW, Kwon BS, Lim SY, Lee YJ, Park JS, Cho YJ, Lee JH, Lee CT, Kim HJ. Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study. 2024 Jan 2;24(1):7. doi: 10.1186/s12890-023-02823-8.
• Kwak N, Henkle E, Hwang H, Jeon D, Jhun BW, Jo KW, Kang YA, Kim HJ, Kim JY, Kim YR, Kwon YS, Lee JH, Mok J, Park Y, Shim TS, Sohn H, Whang J, Yim JJ. Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort. 2024 Jun 14;78(6):1690-1697. doi: 10.1093/cid/ciae131.
• Huh JY, Jeong BH, Yoon HI, Kim H, Cho YJ, Kim C, Lee SJ, Kim HH, Ra SW, Lee YJ, Kim BK, Kim SK, Seo KH, Lee SW. Endobronchial valves for emphysema and persistent air-leak: 10-year experience in an Asian country. 2024 Apr 3;24(1):162. doi: 10.1186/s12890-024-02982-2.
• Kim WY, Jung SY, Kim JY, Chae G, Kim J, Joh JS, Park TY, Baek AR, Jegal Y, Chung CR, Lee J, Cho YJ, Park JH, Hwang JH, Song JW. ECMO is associated with decreased hospital mortality in COVID-19 ARDS. 2024 Jun 27;14(1):14835. doi: 10.1038/s41598-024-64949-x.
• Kim KY, Kang HH, Cho YJ, Kim SH, Lee SH, Kim SW. Knowledge and Attitudes Toward Obstructive Sleep Apnea Among Korean Pulmonologists: A Nationwide Survey. 2024 Jun 5;16(6):e61747. doi: 10.7759/cureus.61747.
• Hwang J, You S, Lee YJ, Sun JS. Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis. 2025 Jan;35(1):276-288. doi: 10.1007/s00330-024-10952-9. Epub 2024 Jul 19.
• Bae E, Hwang H, Kim JY, Park YS, Cho J. Safety and risk factors for bleeding complications of radial probe endobronchial ultrasound-guided transbronchial biopsy. 2024 Jan-Dec:18:17534666241273017.
• Kim J, Eo EY, Kim B, Lee H, Kim J, Koo BK, Kim HJ, Cho S, Kim J, Cho YJ. Transcriptomic Analysis of Air-Liquid Interface Culture in Human Lung Organoids Reveals Regulators of Epithelial Differentiation. 2024 Dec 2;13(23):1991. doi: 10.3390/cells13231991.
• Kwak N, Henkle E, Hwang H, Jeon D, Jhun BW, Jo KW, Kang YA, Kim HJ, Kim JY, Kim YR, Kwon YS, Lee JH, Mok J, Park Y, Shim TS, Sohn H, Whang J, Yim JJ.. Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort. 2024 Jun 14;78(6):1690-1697. doi: 10.1093/cid/ciae131.
• Park Y, Kim HJ, Kim YW, Kwon BS, Lee YJ, Cho YJ, Lee JH, Kim J, Kim J, Lee KH, Park JS. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A case-control study. 2024 Sep:231:107738. doi: 10.1016/j.rmed.2024.107738. Epub 2024 Jul 9.
• Lim SY, Park JS, Cho YJ, Lee JH, Lee CT, Lee YJ. Association of baseline muscle mass with functional outcomes in intensive care unit survivors: A single-center retrospective cohort study in Korea. 2024 Aug 9;103(32):e39156.
• Yoon SH, Kim HJ, Kim J, Kim J, Lee JH. Nontuberculous mycobacterial pulmonary disease presenting as bronchiolitis pattern on CT without cavity or bronchiectasis. 2024 Sep 2;24(1):432. doi: 10.1186/s12890-024-03223-2.
• Kim J, Chae G, Kim WY, Chung CR, Cho YJ, Lee J, Jegal Y, Joh JS, Park TY, Hwang JH, Nam BD, Yoon HY, Song JW. Pulmonary fibrosis followed by severe pneumonia in patients with COVID-19 infection requiring mechanical ventilation: a prospective multicentre study. 2024 Oct 4;11(1):e002538. doi: 10.
• Yoo JW, Kim WY, Chung CR, Cho YJ, Lee J, Jegal Y, Kim J, Joh JS, Park TY, Baek AR, Park JH, Chae G, Hwang JH, Song JW. Early pulmonary fibrosis-like changes between delta and pre-delta periods in patients with severe COVID-19 pneumonia on mechanical ventilation. 2024 Oct 30;14(1):26101. doi: 10.1038/s41598-024-77405-7.

순환기내과

• Park CS, Kim H, Lee SR, Lee JH, Cho Y, Choi EK, Oh IY, Oh S. Prognostic implication of early recurrence after cryoballoon ablation in patients with atrial fibrillation. J Interv Card Electrophysiol. 2024 Mar;67(2):285-292.
• Lee S, Yoon CH, Oh DH, Anh TQ, Jeon KH, Chae IH, Park KD. Gelatin microgel-coated balloon catheter with enhanced delivery of everolimus for long-term vascular patency. Acta Biomater. 2024 Jan 1;173:314-324.
• Choi HM, Hwang IC, Choi HJ, Yoon YE, Lee HJ, Park JB, Lee SP, Kim HK, Kim YJ, Cho GY. Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients. Int J Cardiol. 2024 Feb 15;397:131611.
• Suh JW, Memtsas V, Gue YX, Cho HW, Lee W, Kang SH, Gorog DA. Association between toothbrushing and cardiovascular risk factors: a cross-sectional study using Korean National Health and Nutrition Examination Survey 2015–2017. Thromb Haemost. 2024 Jun;124(6):501-516.
• Moon MG, Kang SH, Kim SH, Park SY, Seol YJ, Yoon CH, Lee HJ, Youn TJ, Chae IH, Leira Y, Munoz-Aguilera E, D'Aiuto F. Association between toothbrushing and cardiovascular risk factors: a cross-sectional study using Korean National Health and Nutrition Examination Survey 2015–2017. BMC Oral Health. 2024 Jan 2;24(1):4.
• Hyun-Wook Chu, In-Chang Hwang, Hyue Mee Kim, Jiesuck Park, Hyejung Choi, Hong-Mi Choi, Yeonyee E Yoon, Goo-Yeong Cho. Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension. Hypertens Res. 2024 May;47(5):1144-1156.
• Park J, Ahn HB, Choi H, Choi HM, Hwang IC, Yoon YE, Cho GY. Integrative Assessment of Cardiopulmonary Fitness Using Cardiopulmonary Exercise Test With Supine Bicycle Echocardiography in Patients Presenting Dyspnea. J Am Heart Assoc. 2024 Mar 19;13(6).
• Choi J, Kim JY, Cho MS, Kim M, Kim J, Oh IY, Cho Y, Lee JH. Artificial intelligence predicts undiagnosed atrial fibrillation in patients with embolic stroke of undetermined source using sinus rhythm electrocardiograms. Heart Rhythm. 2024 Sep;21(9):1647-1655.
• Su A Noh , Hwang-Soo Kim , Si-Hyuck Kang , Chang-Hwan Yoon , Tae-Jin Youn , In-Ho Chae. History and evolution of blood pressure measurement. Clin Hypertens. 2024 Apr 1;30(1):9.
• Jeong D, Jung S, Yoon YE, Jeon J, Jang Y, Ha S, Hong Y, Cho J, Lee SA, Choi HM, Chang HJ. Artificial intelligence-enhanced automation for M-mode echocardiographic analysis: ensuring fully automated, reliable, and reproducible measurements. Int J Cardiovasc Imaging. 2024 Jun;40(6):1245-1256.
• Yoon M, Lee S, Choi JY, Jung MH, Youn JC, Shim CY, Choi JO, Kim EJ, Kim H, Yoo BS, Son YJ, Choi DJ. Effectiveness of a Smartphone App-Based Intervention With Bluetooth-Connected Monitoring Devices and a Feedback System in Heart Failure (SMART-HF Trial): Randomized Controlled Trial. J Med Internet Res. 2024 Apr 29;26:e52075.
• Minjae Yoon , Sung-Ji Park , Byung-Su Yoo , Dong-Ju Choi. The effect of sustained-release CARvedilol in patients with hypErtension and heart failure with preserved ejection fraction: a study protocol for a pilot randomized controlled trial (CARE-preserved HF). J Med Internet Res. 2024 Apr 29:26:e52075.
• Kwun JS, Choi J, Yoon YE, Choi HM, Park JY, Kim HJ, Lee MJ, Choi BY, Yoo S, Suh JW. Prospective validation of a mobile health application for blood pressure management in patients with hypertensive disorders of pregnancy: study protocol for a randomized controlled trial. Trials. 2024 Jul 2;25(1):435.
• Cho Y, Yoon M, Kim J, Lee JH, Oh IY, Lee CJ, Kang SM, Choi DJ. Artificial Intelligence-Based Electrocardiographic Biomarker for Outcome Prediction in Patients With Acute Heart Failure: Prospective Cohort Study. J Med Internet Res. 2024 Jul 3:26
• Park J, Jeon J, Yoon YE, Jang Y, Kim J, Jeong D, Lee J, Hong Y, Ha S, Reza A, Park HB, Lee SA, Choi H, Choi HM, Hwang IC, Cho GY, Chang HJ. Artificial intelligence-enhanced automation of left ventricular diastolic assessment: a pilot study for feasibility, diagnostic validation, and outcome prediction. Cardiovasc Diagn Ther. 2024 Jun 30;14(3):352-366.
• Jeon KH, Lee HS, Kang S, Jang JH, Jo YY, Son JM, Lee MS, Kwon JM, Kwun JS, Cho HW, Kang SH, Lee W, Yoon CH, Suh JW, Youn TJ, Chae IH. AI-enabled ECG index for predicting left ventricular dysfunction in patients with ST-segment elevation myocardial infarction. Sci Rep. 2024 Jul 17;14(1):16575.
• Yoonpyo Lee , Minjae Yoon , Dong-Ju Choi , Jin Joo Park. Differential Effect of Sex on Mortality According to Age in Heart Failure. J Am Heart Assoc. 2024 Aug 6;13(15)
• Park J, Kim J, Kang SH, Lee J, Hong Y, Chang HJ, Cho Y, Yoon YE. Artificial intelligence-enhanced electrocardiography analysis as a promising tool for predicting obstructive coronary artery disease in patients with stable angina. European Heart Journal - Digital Health (2024) 00, 1–10.
• Hyun-Woo Kim , Soon-Cheol Noh , Sun-Hwa Kim , Hyun-Wook Chu , Chung-Hwan Jung , Si-Hyuck Kang. Effective descriptor extraction strategies for correspondence matching in coronary angiography images. Sci Rep. 2024 Aug 11;14(1):18630.
• Cho YH, Park JJ, Lee HY, Kim KH, Yoo BS, Kang SM, Baek SH, Jeon ES, Kim JJ, Cho MC, Chae SC, Oh BH, Choi DJ. J-shaped relationship between serum creatinine and mortality in Korean patients with acute heart failure. Clin Res Cardiol. 2024 Aug 27.
• Yoon M, Kim W, Kook W, Park JJ, Greenberg B. Analysis of the PARAGON-HF Study Results Using Win Ratio. Circ Heart Fail. 2024 Sep;17(9).
• Youngjin Cho, Joonghee Kim. Could ChatGPT Become a Future Cardiologist? Navigating Requirements and Risks. Journal of Cardiovascular Medicine. 2024 Nov 1;25(11):772-774.
• Cho Y, Kim JS, Kim J, Yoon YE, Jung SY. Image-Based ECG Analyzing Deep-Learning Algorithm to Predict Biological Age and Mortality Risks: Interethnic Validation. Journal of Cardiovascular Medicine. 2024 Nov 1;25(11):781-788.
• Chu HW, Yoon CH, Han D, Seo WW, Park SD, Doh JH, Nam CW, Shin ES, Koo BK, Chae IH, Youn TJ. Diagnostic performance of angiography-derived fractional flow reserve compared to pressure wire-derived fractional flow reserve: Rationale and design of MPFFR pivotal trial. Cardiovasc Revasc Med. 2024 Sep 24:S1553-8389(24)00677-8.
• Kim CH, Lee SH, Kim HK, Kim MC, Kim JH, Hong YJ, Ahn YK, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM; KAMIR-NIH Investigators. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction. Circ J. 2024 Jul 25;88(8):1237-1245.
• Park SJ, Ahn JM, Kang DY, Yun SC, Ahn YK, Kim WJ, Nam CW, Jeong JO, Chae IH, Shiomi H, Kao HL, Hahn JY, Her SH, Lee BK, Ahn TH, Chang KY, Chae JK, Smyth D, Mintz GS, Stone GW, Park DW; PREVENT Investigators. Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Lancet. 2024 May 4;403(10438):1753-1765.
• Joh HS, Lee SH, Jo J, Kim HK, Lim WH, Kim HL, Seo JB, Chung WY, Kim SH, Zo JH, Kim MA, Kim MC, Kim JH, Hong YJ, Ahn YK, Jeong MH, Hur SH, Kim DI, Chang K, Park HS, Bae JW, Jeong JO, Park YH, Yun KH, Yoon CH, Kim Y, Hwang JY, Kim HS, Hong D, Kwon W, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM; KAMIR Investigators. Intravascular imaging-guided percutaneous coronary intervention in patients with acute myocardial infarction and cardiogenic shock. Rev Esp Cardiol (Engl Ed). 2024 Dec;77(12):995-1007.
• Ahn HJ, Oh IY, Choi J, Lee KY, Ahn HJ, Kwon S, Choi EK, Oh S, Kim JY, Cha MJ, Kwon CH, Lee SH, Park J, Kim KH, Yang PS, Kim JH, Shim J, Lim HE, Lee SR. Association between body mass index and results of cryoballoon ablation in Korean patients with atrial fibrillation: an analysis from the Korean Heart Rhythm Society Cryoablation registry. Europace. 2024 May 2;26(5):euae095.
• Cha JJ, Lee SJ, Park JH, Hong SJ, Ahn TH, Chang K, Park Y, Song YB, Ahn SG, Suh JW, Lee SY, Cho JR, Her AY, Jeong YH, Kim HS, Kim MH, Shin ES, Kim BK, Lim DS. Association of Age- and Body Mass Index-Stratified High On-Treatment Platelet Reactivity With Coronary Intervention Outcomes in East Asian Patients. J Am Heart Assoc. 2024 May 7;13(9):e031819.
• Lee KS, Kim H, Lee SH, Choi DJ, Yoon M, Jeon ES, Choi JO, Kang J, Lee HY, Jung SH, Oh J, Kang SM, Lee SY, Ju MH, Kim JJ, Kim MS, Cho HJ. Impact of Everolimus Initiation and Corticosteroid Weaning During Acute Phase After Heart Transplantation on Clinical Outcome: Data from the Korean Organ Transplant Registry (KOTRY). Transpl Int. 2024 Apr 5:37:11878.
• Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Safety of the PCSK9 inhibitor alirocumab: insights from 47?296 patient-years of observation. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352.
• Kang DH, Park SJ, Shin SH, Hwang IC, Yoon YE, Kim HK, Kim M, Kim MS, Yun SC, Song JM, Kang SM. Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial. Circulation. 2024 Jun 11;149(24):1865-1874.
• Lee OH, Heo SJ, Johnson TW, Kim Y, Cho DK, Kim JS, Kim BK, Choi D, Hong MK, Jang Y, Jeong MH; Investigators for KAMIR. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock. Sci Rep. 2024 May 1;14(1):10028.
• Kim Y, Park H, Yoon HJ, Suh J, Kang SH, Lim YH, Jang DH, Park JH, Shin ES, Bae JW, Lee JH, Oh JH, Kang DY, Kweon J, Jo MW, Park DW, Kim YH, Ahn JM; FLASH Trial Investigators. Fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation (FLASH): Study protocol for a randomized controlled noninferiority trial. Am Heart J. 2024 Sep:275:86-95.
• Gautier A, Picard F, Ducrocq G, Elbez Y, Fox KM, Ferrari R, Ford I, Tardif JC, Tendera M, Steg PG; CLARIFY investigators. New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. Eur Heart J. 2024 Feb 1;45(5):366-375.
• Kim H, Kang DY, Lee J, Choi Y, Ahn JM, Kim S, Yoon YH, Hur SH, Lee CH, Kim WJ, Kang SH, Park CS, Lee BK, Suh JW, Choi JW, Kim KS, Lee SN, Park SJ, Park DW. Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial. Eur Heart J. 2024 Mar 1;45(9):653-665.
• Lee JM, Kim H, Lee JY, Choi KH, Song YB, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY; RENOVATE COMPLEX-PCI Investigators. Optical Coherence Tomography Compared With Intravascular Ultrasound and Angiography in Complex Coronary Artery Lesions. JACC Cardiovasc Imaging. 2024 Mar;17(3):336-338.
• Park JH, Ahn SK, Cho GY, Sung KC, Lee SK, Kim SH, Shin C. Increased Blood Pressure Variability Over a 16-Year Period Is Associated With Left Ventricular Diastolic Dysfunction in a Population-Based Cohort. Am J Hypertens. 2024 Feb 15;37(3):168-178.
• Chun KH, Oh J, Lee CJ, Park JJ, Lee SE, Kim MS, Cho HJ, Choi JO, Lee HY, Hwang KK, Kim KH, Yoo BS, Choi DJ, Baek SH, Jeon ES, Kim JJ, Cho MC, Chae SC, Oh BH, Kang SM. Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data. Am J Hypertens. 2024 Feb 15;37(3):168-178.
• Lim S, Hong SJ, Kim JH, Cha JJ, Joo HJ, Park JH, Yu CW, Kim BK, Chang K, Park Y, Song YB, Ahn SG, Suh JW, Lee SY, Cho JR, Her AY, Jeong YH, Kim HS, Kim MH, Shin ES, Lim DS; PTRG Investigators. High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation. Sci Rep. 2024 Jan 4;14(1):520.
• Lee CJ, Kang WC, Ihm SH, Sohn IS, Woo JS, Kim JW, Hong SJ, Choi JH, Suh JW, Seo JB, Doh JH, Son JW, Park JH, Lee JH, Hong YJ, Heo JH, Shin J, Kang SM. Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial. J Clin Hypertens (Greenwich). 2024 Mar;26(3):262-273.
• Kim ES, Park SK, Cho DS, Youn JC, Lee HS, Lee HY, Cho HJ, Choi JO, Jeon ES, Lee SE, Kim MS, Kim JJ, Hwang KK, Cho MC, Chae SC, Kang SM, Park JJ, Choi DJ, Yoo BS, Cho JY, Kim KH, Oh BH, Greenberg B, Baek SH. Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea. Am J Cardiovasc Drugs. 2024 Mar;24(2):313-324.
• Lee JM, Kim H, Park YS, Jo HH, Lim SM, Lee J, Choi Y, Kang DY, Ahn JM, Kim S, Yoon YH, Hur SH, Lee CH, Kim WJ, Kang SH, Park CS, Lee BK, Suh JW, Choi JW, Kim KS, Lee SN, Park SJ, Park DW; POST-PCI Investigators. Surveillance Stress Testing After Percutaneous Intervention for Patients?With Multivessel or Left?Main?Coronary Disease. J Am Coll Cardiol. 2024 Mar 5;83(9):890-900.
• Cha J, Choi SY, Rha SW, Choi BG, Byun JK, Hyun S, Lee MW, Kang J, Chu W, Park EJ, Kang DO, Choi CU, Kim SW, Jeong MH, Park S; Korea Acute Myocardial Infraction Registry study group. Long-term air pollution exposure is associated with higher incidence of ST-elevation myocardial infarction and in-hospital cardiogenic shock. Sci Rep. 2024 Feb 29;14(1):4976.
• Soo Lim , Jae Hyun Bae , Heran Oh , In-Chang Hwang , Yeonyee E Yoon , Goo-Yeong Cho. Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial. Cardiovasc Diabetol. 2024 Oct 22;23(1):373.
• Park J, Ahn HB, Choi H, Choi HM, Hwang IC, Yoon YE, Cho GY. Integrative Assessment of Cardiopulmonary Fitness Using Cardiopulmonary Exercise Test With Supine Bicycle Echocardiography in Patients Presenting Dyspnea. J Am Heart Assoc. 2024 Mar 19;13(6):e033815.
• Cha JH, Lee JM, Choi KH, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY, Lee WS, Song YB; RENOVATE-COMPLEX-PCI Investigators. Intravascular Imaging-Guided Optimization of Complex Percutaneous Coronary Intervention by Sex: A Subgroup Analysis of the RENOVATE-COMPLEX-PCI Trial. JAMA Cardiol. 2024 May 1;9(5):466-474.
• Park MJ, Choi YJ, Shim M, Cho Y, Park J, Choi J, Kim J, Lee E, Kim SY. Performance of ECG-Derived Digital Biomarker for Screening Coronary Occlusion in Resuscitated Out-of-Hospital Cardiac Arrest Patients: A Comparative Study between Artificial Intelligence and a Group of Experts. Journal of Clinical Medicine. 2024 Feb 27;13(5):1354.
• Bucci T, Romiti GF, Corica B, Shantsila A, Teo WS, Park HW, Shimizu W, Tse HF, Proietti M, Chao TF, Lip GYH; Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry. Minerva Med. 2024 Jun;115(3):308-319.
• Rhee TM, Ko YK, Kim HK, Lee SB, Kim BS, Choi HM, Hwang IC, Park JB, Yoon YE, Kim YJ, Cho GY. Machine Learning-Based Discrimination of Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy. JACC Asia. 2024 Feb 20;4(5):375-386.
• Lee SY, Choi KH, Kim CJ, Lee JM, Song YB, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Kim SE, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Park TK, Yang JH, Choi SH, Gwon HC, Hahn JY; RENOVATE-COMPLEX-PCI Investigators. Impact of Intravascular Imaging-Guided Stent Optimization According to Clinical?Presentation in Patients Undergoing Complex PCI. JACC Cardiovasc Interv. 2024 May 27;17(10):1231-1243.
• Park J, Cha MJ, Kwon CH, Cho MS, Nam GB, Oh IY, Lee SR, Kim JY, Lee SH, Park J, Kim KH, Yang PS, Kim JH, Shim J, Lim HE. Long-term clinical impact of early recurrence of atrial tachyarrhythmia after cryoballoon ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2024 Aug;35(8):1614-1623.
• Choi KH, Park TK, Song YB, Lee JM, Lee JY, Lee SJ, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Yoon HJ, Park YH, Lee WS, Jeong JO, Song PS, Doh JH, Jo SH, Yoon CH, Kang MG, Koh JS, Lee KY, Lim YH, Cho YH, Cho JM, Jang WJ, Chun KJ, Hong D, Yang JH, Choi SH, Gwon HC, Hahn JY, Nam CW; RENOVATE COMPLEX-PCI Investigators. Intravascular Imaging and Angiography Guidance in Complex Percutaneous Coronary Intervention Among Patients With Diabetes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 3;7(6):e2417613.
• Choi J, Lee SR, Kwon S, Ahn HJ, Lee KY, Park JS, Choi JI, Lee SH, Heo JH, Oh IY, On YK, Yu HT, Lee KN, Kim NH, Park HW, Lee KH, Shin SY, Oh S, Lip GYH, Han S, Choi EK. Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study. Front Cardiovasc Med. 2024 Jun 10:11:1367623.
• Lee J, Kang DY, Kim H, Choi Y, Jo S, Ahn JM, Kim S, Yoon YH, Hur SH, Lee CH, Kim WJ, Kang SH, Park CS, Lee BK, Suh JW, Choi JW, Kim KS, Lee SN, Park SJ, Park DW. Routine Stress Testing After PCI in Patients With and Without Acute Coronary Syndrome: A Secondary Analysis of the POST-PCI Randomized Clinical Trial. JAMA CardiolJAMA Cardiol. 2024 Sep 1;9(9):770-780.
• Pisanò ECL, Calvi V, Viscusi M, Rapacciuolo A, Lazzari L, Bontempi L, Pelargonio G, Arena G, Caccavo V, Wang CC, Merkely B, Lin LY, Oh IY, Bertaglia E, Saporito D, Menichelli M, Nicosia A, Carretta DM, Coppolino A, Ching CK, Del Castillo ÁM, Su X, Del Maestro M, Giacopelli D, Gargaro A, Botto GL. Closed loop stimulation reduces the incidence of atrial high-rate episodes compared with conventional rate-adaptive pacing in patients with sinus node dysfunctions. Europace. 2024 Jul 2;26(7):euae175.
• Kim MN, Lee YS, Park Y, Jung A, So H, Park J, Park JJ, Choi DJ, Kim SR, Park SM. Deep learning for predicting rehospitalization in acute heart failure: Model foundation and external validation. ESC Heart Fail. 2024 Dec;11(6):3702-3712.
• Joh HS, Kwon W, Shin D, Lee SH, Hong YJ, Hong D, Lee SY, Park H, Kim S, Lee SY, Koh JS, Kim H, Kim CJ, Choo EH, Yoon HJ, Park SD, Jeon KH, Bae JW, Ahn SG, Kim SE, Choi KH, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Gwon HC, Lee JM. Drug-Coated Balloon Angioplasty in Patients Undergoing Complex Percutaneous Coronary Intervention. JACC Asia. 2024 Jun 18;4(7):519-531.
• Kang J, Abdul Ghapar AK, Selvaraj K, Hur SH, Tam CC, Jang Y, Chae IH, Kandzari DE, Kirtane AJ, Latib A, Kedhi E, Lung TH, You SJ, Windecker S, Stone GW, Kim HS. One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention - Onyx ONE Clear 2-Year Results. Circ Rep. 2024 Jul 6;6(8):333-340.
• Lee J, Choi JY, Choi BG, Choi YJ, Park S, Kang DO, Park EJ, Kim JB, Roh SY, Na JO, Choi CU, Kim EJ, Park CG, Jeong MH, Hwang JY, Hur SH, Jeong JO, Oh S, Rha SW; KAMIR NIH Investigators. Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study. Sci Rep. 2024 Aug 21;14(1):19438.
• Roger G, Ducrocq G, Mesnier J, Sayah N, Abtan J, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Feldman LJ, Elbez Y, Steg PG; CLARIFY Investigators. Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry. Eur Heart J. 2024 Jul 12;45(27):2396-2406.
• Yoo Jin Choi, Min Ji Park, Youngjin Cho, Joonghee Kim, Eunkyoung Lee, Dahyeon Son, Seo-Yoon Kim, Moon Seung Soh. Screening for RV Dysfunction Using Smartphone ECG Analysis App: Validation Study with Acute Pulmonary Embolism Patients. Journal of Clinical Medicine. 2024 Aug 14;13(16):4792.
• Kim K, Kim M, Seo CO, Kim H, Kim HR, Kang MG, Koh JS, Park JR, Kim RB, Ryu DR, Lee JH, Kim MH, Youn TJ, Hyun DW, Kim SJ, Rhee SJ, Park SD, Hong YJ, Lee JG, Song PS, Kim SM, Lee SJ, Hwang JY. Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCC. J Clin Med. 2024 Aug 16;13(16):4840.
• Shin Y, Lee SH, Lee SH, Kim JS, Lim YH, Ahn JH, Cho KH, Kim MC, Sim DS, Hong YJ, Kim JH, Hwang JY, Oh SK, Song PS, Park YH, Hur SH, Yoon CH, Lee JM, Song YB, Hahn JY, Jeong MH, Ahn Y; KAMIR-V Investigators. Optimal timing of revascularization for patients with non-ST segment elevation myocardial infarction and severe left ventricular dysfunction. Medicine (Baltimore). 2024 Aug 30;103(35):e38483.
• Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, Mehta N, Oh JH, Cho YR, Yoon KH, Ahn SG, Lee JH, Cho DK, Kim Y, Kim J, Cho GH, Lee KS, Park H, Vural M, Lim YH, Park KH, Lee BK, Lee JY, Park HW, Yoon YH, Lee JH, Lee SY, Park KW, Kang J, Kim HK, Kang SH, Park JH, Choi IC, Yu CS, Yun SC, Park DW, Hong MK, Park SJ, Kim JS, Ahn JM; ASSURE DES Investigators. J Am Coll Cardiol. 2024 Dec 10;84(24):2380-2389.
• Cho MS, Kang DY, Ahn JM, Yun SC, Oh YS, Lee CH, Choi EK, Lee JH, Kwon CH, Park GM, Choi HO, Park KH, Park KM, Hwang J, Yoo KD, Cho YR, Kim JH, Hwang KW, Jin ES, Kwon O, Kim KH, Park SJ, Park DW, Nam GB; EPIC-CAD Investigators. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease. N Engl J Med. 2024 Dec 5;391(22):2075-2086.
• Kim D, Shim J, Choi EK, Oh IY, Kim J, Lee YS, Park J, Ko JS, Park KM, Sung JH, Park HW, Park HS, Kim JY, Yu HT, Kim TH, Joung B. The anticoagulation one year after ablation of atrial fibrillation in patients with atrial fibrillation (ALONE-AF) trial: Study protocol. Heliyon. 2024 Aug 16;10(16):e36506.
• Kang J, Park SH, Park KW, Koo BK, Lee H, Han M, Hwang D, Yang HM, Chae IH, Shin WY, Oh JH, Kim YH, Park TH, Kim BS, Han JK, Shin ES, Kim HS. Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST-EXAM Trial. J Am Heart Assoc. 2024 Sep 17;13(18):e035269.
• Kim YH, Her AY, Ko YG, Ahn CM, Lee SJ, Hong MK, Yu CW, Lee JH, Lee SW, Youn YJ, Yoon CH, Rha SW, Min PK, Choi SH, Chae IH, Choi D; K-VIS ELLA Investigators. Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches. Sci Rep. 2024 Sep 11;14(1):21173.
• Song JK, Lee S, Kim YJ, Kim HK, Ha JW, Choi EY, Park SW, Park SJ, Park YH, Park JH, Yang DH, Kim KH, Yang DH, Han S, Chae SY, Lee JS, Song JM, Cho GY. Effect of Evogliptin on the Progression of Aortic Valvular Calcification. J Am Coll Cardiol. 2024 Sep 17;84(12):1064-1075.
• Yoon YH, Lee JH, Hwang WM, Park HW, Roh JH, Lee SJ, Ko YG, Ahn CM, Yu CW, Lee SW, Youn YJ, Park JK, Yoon CH, Rha SW, Min PK, Choi SH, Chae IH, Choi D, On Behalf OTKI. Treatment extent of femoropopliteal disease and clinical outcomes following endovascular therapy. EuroIntervention. 2024 Sep 16;20(18):e1154-e1162.
• Lim S, Bae JH, Oh H, Hwang IC, Yoon YE, Cho GY. Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial. Cardiovasc Diabetol. 2024 Oct 22;23(1):373.
• Tompkins JD, Hoover DB, Havton LA, Patel JC, Cho Y, Smith EH, Biscola NP, Ajijola OA, Shivkumar K, Ardell JL. Comparative specialization of intrinsic cardiac neurons in humans, mice, and pigs. The Journal of Physiology. 2024 Nov 8.
• Hong D, Dai N, Lee SH, Shin D, Choi KH, Kim SM, Kim HK, Jeon KH, Ha SJ, Lee KY, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Choe YH, Gwon HC, Ge J, Lee JM. Fractional Flow Reserve and Fractional Flow Reserve Gradient From CCTA for Predicting Future Coronary Events. JACC Asia. 2024 Aug 27;4(10):735-747.
• Choi KH, Kim J, Kang D, Doh JH, Kim J, Park YH, Ahn SG, Kim W, Park JP, Kim SM, Cho BR, Nam CW, Cho JH, Joo SJ, Suh J, Jeong JO, Jang W, Yoon CH, Hwang JY, Lim SH, Lee SR, Shin ES, Kim BJ, Yu CW, Her SH, Kim HK, Park KT, Kim J, Park TK, Lee JM, Cho J, Yang JH, Song YB, Choi SH, Gwon HC, Guallar E, Hahn JY; SMART-DECISION investigators. Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial. BMJ Open. 2024 Aug 31;14(8):e086971.
• Kang J, Jeon KH, Choi KU, Choi HI, Sung KC. Brachial-Ankle Pulse Wave Velocity as a Predictor of Diabetes Development: Elevated Risk Within Normal Range Values in a Low-Risk Population. J Am Heart Assoc. 2024 Dec 17;13(24):e037705.
• Hudec M, Jeong MH, Trillo R, Ijsselmuiden AJJ, Gwon HC, Chae IH, Wang YC, de Costa JM, Charng MJ, Maskon O, Burgos JM, Mayurathan G, Mateev H, Serra A, Merkely B, Cale R, Hwang SJ, Mar GY, Lawand S, Khokhlov A, Montilla BV, Valdes M, Sadeghian M. Safety and Efficacy of BioMime Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: MILES Global Registry. Cardiol Res. 2024 Dec;15(6):439-452.
• Lee HY, Min KW, Han KA, Kim JS, Ahn JC, Kim MH, Lee JB, Shin SH, Kim CJ, Kim KH, Cho DK, Choi J, Rhee MY, Her SH, Kim W, Na JO, Cho GY, Kim SY, Park GM, Lee BK, Jo SH, Lee BW, Sohn IS, Kim DI, Ihm SH, Lee SH, Chung JW, Cho EJ, Son JW, Oh SJ, Hwang JY, Jeong JO, Han KR, Yoon HJ, Seo SM, Chung WJ, Bae JW, Choi JH, Hyun BJ, Cha JE, Yoo SJ, Shin J. The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy. Clin Ther. 2024 Jun;46(6):481-489.
• Rhee TM, Ko YK, Kim HK, Lee SB, Kim BS, Choi HM, Hwang IC, Park JB, Yoon YE, Kim YJ, Cho GY. Machine Learning-Based Discrimination?of Cardiovascular Outcomes in Patients With Hypertrophic?Cardiomyopathy. JACC Asia. 2024 Feb 20;4(5):375-386.
• Song JK, Lee S, Kim YJ, Kim HK, Ha JW, Choi EY, Park SW, Park SJ, Park YH, Park JH, Yang DH, Kim KH, Yang DH, Han S, Chae SY, Lee JS, Song JM, Cho GY. Effect of Evogliptin on the Progression of Aortic Valvular Calcification. J Am Coll Cardiol. 2024 Sep 17;84(12):1064-1075. Effect of Evogliptin on the Progression of Aortic Valvular Calcification. J Am Coll Cardiol. 2024 Sep 17;84(12):1064-1075.

소화기내과

• Choi Y, Kim N. Sex Difference of Colon Adenoma Pathway and Colorectal Carcinogenesis. World J Mens Health. 2024 Apr;42(2):256-282.
• Chang YH, Shin CM, Han K, Jung JH, Jin EH, Lim JH, Kang SJ, Choi YJ, Yoon H, Park YS, Kim N, Lee DH. The Persistence of Hypertriglyceridemia and the Risk of Early Onset Colorectal Cancer According to Tumor Subsites: A Nationwide Population-Based Study. Cancer Res Treat. 2024 Jul;56(3):825-837.
• Lee KH, Choi GH, Yun J, Choi J, Goh MJ, Sinn DH, Jin YJ, Kim MA, Yu SJ, Jang S, Lee SK, Jang JW, Lee JS, Kim DY, Cho YY, Kim HJ, Kim S, Kim JH, Kim N, Kim KM. Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study. NPJ Digit Med. 2024 Jan 5;7(1):2.
• Kim JH, Kim N, Song DH, Choi Y, Jeon EB, Kim S, Jun YK, Yoon H, Shin CM, Park YS, Lee DH, Oh HJ, Lee HS, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Ahn S. Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study. Gastric Cancer. 2024 Mar;27(2):221-234.
• Park J, Chun J, Park SJ, Park JJ, Kim TI, Yoon H, Cheon JH. Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study. Dig Dis Sci. 2024 Mar;69(3):901-910.
• Park MK, Hur MH, Moon HS, Shin H, Chung SW, Won S, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ. Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study. Liver Int. 2024 Mar;44(3):799-810.
• Lee HK, Kim NE, Shin CM, Oh TJ, Yoon H, Park YS, Kim N, Won S, Lee DH. Gut microbiome signature of metabolically healthy obese individuals according to anthropometric, metabolic and inflammatory parameters. Sci Rep. 2024 Feb 11;14(1):3449.
• Han KH, Choi YJ, Han K, Shin CM, Park NH, Lee DH. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study. Maturitas. 2024 Jun;184:107960.
• Choi SI, Kim N, Nam RH, Jang JY, Kim EH, Ha S, Kang K, Lee W, Shin CM, Lee DH. Sex Difference in the Effect of Bifidobacterium longum on Repeated Water Avoidance Stress-induced Gut Dysbiosis in Wistar Rats. J Cancer Prev. 2024 Mar 30;29(1):16-23.
• Kang SJ, Shin CM, Han K, Jung JH, Jin EH, Lim JH, Choi YJ, Yoon H, Park YS, Kim N, Lee DH. Impact of Smoking and Alcohol Consumption on Early-Onset Gastric Cancer Development in Young Koreans: A Population-Based Study. J Gastric Cancer. 2024 Apr;24(2):145-158.
• Jun YK, Ji E, Yang HR, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Yoon H. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study. Therap Adv Gastroenterol. 2024 May 12;17:17562848241248321.
• Choi YH, Seo SI, Jung DH, Kim JS, Kim SY, Lim HC, Youn YH. Awareness of Proton Pump Inhibitor Adverse Events and Treatment Pattern Change According to Physician Practice: A National Questionnaire Study in Korea. J Pers Med. 2024 May 15;14(5):529.
• Jang DK, Kim YA, Lee JW, Kim HJ, Lee YS, Chun JW, Lee JC, Woo SM, Hwang JH. The Trends and Outcomes of Initial Palliative Chemotherapy in Patients with Pancreatic Cancer in Korea Based on National Health Insurance Service Data. J Clin Med. 2024 May 30;13(11):3229.
• Choi Y, Kim N, Song CH, Kim S, Lee DH. The Effect of A2 Milk on Gastrointestinal Symptoms in Comparison to A1/A2 Milk: A Single-center, Randomized, Double-blind, Cross-over Study. J Cancer Prev. 2024 Jun 30;29(2):45-53.
• Chang YH, Shin CM, Lee HD, Park J, Jeon J, Cho SJ, Kang SJ, Chung JY, Jun YK, Choi Y, Yoon H, Park YS, Kim N, Lee DH. Real-World Application of Artificial Intelligence for Detecting Pathologic Gastric Atypia and Neoplastic Lesions. J Gastric Cancer. 2024 Jul;24(3):327-340.
• Lee HK, Shin CM, Chang YH, Yoon H, Park YS, Kim N, Lee DH. Gastric microbiome signature for predicting metachronous recurrence after endoscopic resection of gastric neoplasm. Gastric Cancer. 2024 Sep;27(5):1031-1045.
• Yoon H, Ye BD, Kang SB, Lee KM, Choi CH, Jo JY, Woo J, Cheon JH. Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study. BMC Gastroenterol. 2024 Aug 19;24(1):273.
• Lee JW, Kim N, Lee J, Jo SY, Lee DH. Efficacy of Tegoprazan-Containing Sequential Eradication Treatment Compared to Esomeprazole-Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study. Helicobacter. 2024 Sep-Oct;29(5):e13143.
• Jang ES. Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea. Clin Mol Hepatol. 2024 Nov 11.
• Na HY, Kim JH, Kim H, Cho JY, Han HS, Jang ES, Kim JW, Jeong SH, Heo J, Kim JW, Kim JW, Ahn S. Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality. Histopathology. 2024 Jan;84(2):402-408.
• Park J, Lee YB, Ko Y, Park Y, Shin H, Hur MH, Park MK, Lee DW, Cho EJ, Lee KH, Lee JH, Yu SJ, Kim TY, Kim YJ, Kim TY, Yoon JH. Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis. J Liver Cancer. 2024 Mar;24(1):81-91.
• Huh Y, Kim YJ, Choi JY, Lee JE, Jung HW, Shin CM, Won CW, Son KY. Comparison of anticholinergic burden with chronic polypharmacy on functional decline and mortality in Korean older people: a retrospective nationwide cohort study. BMC Geriatr. 2024 Jan 23;24(1):90.
• Do HE, Ha YB, Kim JS, Suh MK, Kim HS, Eom MK, Lee JH, Park SH, Kang SW, Lee DH, Yoon H, Lee JH, Lee JS. Phocaeicola acetigenes sp. nov., producing acetic acid and iso-butyric acid, isolated faeces from a healthy human. Antonie Van Leeuwenhoek. 2024 Feb 1;117(1):30.
• Kim HS, Kim JS, Suh MK, Eom MK, Do HE, Lee JH, Park SH, Kang SW, Lee DH, Yoon H, Lee JH, Lee JS. Gordonibacter faecis sp. nov., producing urolithin C from ellagic acid, isolated from feces of healthy Korean subjects. Arch Microbiol. 2024 Feb 18;206(3):108.
• Yoon JS, Hong JH, Park SY, Kim SU, Kim HY, Kim JY, Hur MH, Park MK, Lee YB, Lee HA, Kim GA, Sinn DH, Park SJ, Lee YJ, Kim YJ, Yoon JH, Lee JH. High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study. Aliment Pharmacol Ther. 2024 Apr;59(8):973-983.
• Choi WM, Yip TC, Kim WR, Yee LJ, Brooks-Rooney C, Curteis T, Clark LJ, Jafry Z, Chen CH, Chen CY, Huang YH, Jin YJ, Jun DW, Kim JW, Park NH, Peng CY, Shin HP, Shin JW, Yang YH, Wong GL, Lim YS. Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients. Hepatology. 2024 Aug 1;80(2):428-439.
• Chung SW, Moon HS, Shin H, Han H, Park S, Cho H, Park J, Hur MH, Park MK, Won SH, Lee YB, Cho EJ, Yu SJ, Kim DK, Yoon JH, Lee JH, Kim YJ. Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study. Hepatology. 2024 Sep 1;80(3):633-648.
• Kim BH, Park H, Shin CM, Huh G, Jung YH, Jeong WJ. Prediction of the efficacy of proton-pump inhibitors in patients with contact granuloma using 24-hour combined dual channel pH/impedance monitoring. Auris Nasus Larynx. 2024 Jun;51(3):548-552.
• Yoon SB, Woo SM, Chun JW, Kim DU, Kim J, Park JK, So H, Chung MJ, Cho IR, Heo J. The predictive value of PD-L1 expression in response to anti-PD-1/PD-L1 therapy for biliary tract cancer: a systematic review and meta-analysis. Front Immunol. 2024 Mar 28;15:1321813.
• Kim K, Park JJ, Yoon H, Lee J, Kim KO, Kim ES, Kim SY, Boo SJ, Jung Y, Yoo JH, Hwang SW, Park SH, Yang SK, Ye BD; Scientific Committee of the Korean Association for the Study of Intestinal Diseases. Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study. Aliment Pharmacol Ther. 2024 Jun;59(12):1539-1550.
• Kim SA, Choi GH, Lee JY, Jang ES, Lee JO, Kim JW, Jeong SH, Bang SM. Apixaban for the treatment of acute splanchnic vein thrombosis: A pilot study. Thromb Res. 2024 May;237:181-183.
• Kim KY, Yoon CJ, Lee JH, Lee CH, Hwang JH, Kim J. Percutaneous endobiliary radiofrequency ablation with stent placement in type IV hilar cholangiocarcinoma: A prospective comparison with stent placement alone. Eur J Radiol. 2024 Jul;176:111516.
• Sohn W, Park SY, Lee TH, Chon YE, Kim IH, Lee BS, Yoon KT, Jang JY, Lee YR, Yu SJ, Choi WM, Kim SG, Jun DW, Jeong J, Kim JH, Jang ES, Kim HY, Cho SB, Jang BK, Park JG, Lee JW, Seo YS, Lee JI, Song DS, Kim MY, Yim HJ, Sinn DH, Ahn SH, Kim YS, Jang H, Kim W, Han S, Kim SU. Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007-2021: a nationwide, multicentre, retrospective cohort study. EClinicalMedicine. 2024 May 30;73:102671.
• Shin H, Lim GS, Yoon JW, Ko Y, Park Y, Park J, Hur MH, Park MK, Cho Y, Lee YB, Cho EJ, Kim BH, Lee JH, Yu SJ, Yoon JH, Kim YJ. Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B. J Med Virol. 2024 Jul;96(7):e29760.
• Lee S, Jeon J, Park J, Chang YH, Shin CM, Oh MJ, Kim SH, Kang S, Park SH, Kim SG, Lee HJ, Yang HK, Lee HS, Cho SJ. An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video). Gastric Cancer. 2024 Sep;27(5):1088-1099.
• Shin H, Choi WM, Kim SU, Ko Y, Park Y, Park J, Hur MH, Park MK, Lee YB, Kim YJ, Yoon JH, Lee JH, Zoulim F. Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis. JHEP Rep. 2024 Apr 8;6(7):101089.
• Han JW, Sohn W, Choi GH, Jang JW, Seo GH, Kim BH, Choi JY. Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study. J Liver Cancer. 2024 Sep;24(2):274-285.
• Kim GA, Lim YS, Han S, Choi GH, Choi WM, Choi J, Sinn DH, Paik YH, Lee JH, Lee YB, Cho JY, Heo NY, Yuen MF, Wong VW, Chan SL, Yang HI, Chen CJ. Viral load-based prediction of hepatocellular carcinoma risk in noncirrhotic patients with chronic hepatitis B: A multinational study for the development and external validation of a new prognostic model. Ann Intern Med. 2024 Oct;177(10):1308-1318.
• Kim MK, Cho IR, Kim Y, Choi JH, Jung K, Kim J, Kim S, Yun H, Yoon J, Oh DY, Kim K, Lee SH. Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX. Ther Adv Med Oncol. 2024 Oct 23;16:17588359241290482.
• Kim JS, Kwon D, Kim K, Lee SH, Lee SB, Kim K, Kim D, Lee MW, Park N, Choi JH, Jang ES, Cho IR, Paik WH, Lee JK, Ryu JK, Kim YT. Machine learning-based prediction of pulmonary embolism to reduce unnecessary computed tomography scans in gastrointestinal cancer patients: a retrospective multicenter study. Sci Rep. 2024 Oct 25;14(1):25359.
• Choi Y, Kim N, Lim SH, Park JH, Lee JH, Kim Y, Jo H, Lee HK, Choi J, Jun YK, Yoon H, Shin CM, Park YS, Lee DH. Comparison of GastroPanel® and GENEDIA® in Diagnosing Helicobacter pylori Infection and Gastric Lesions. J Cancer Prev. 2024 Dec 30;29(4):148-156.

혈액종양내과

• Seo J, Lee C, Koh Y, Sun CH, Lee JM, An HY, Kim M. Machine-learning-based predictive classifier for bone marrow failure syndrome using complete blood count data. iScience. 2024 Oct 1;27(11):111082.
• Lee SB, Kim JW, Kim HG, Hwang SH, Kim KJ, Lee JH, Seo J, Kang M, Jung EH, Suh KJ, Kim SH, Kim JW, Kim YJ, Kim JH, Kwon NJ, Lee KW. Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy. Cancer Res Treat. 2024 Oct;56(4):1171-1182.
• Choi S, Kang M, Kim JW, Kim JW, Jeon JH, Oh HK, Lee HW, Cho JY, Kim DW, Cho S, Kim JH, Kim K, Kang SB, Jheon S, Lee KW. Long-term clinical outcomes after the second metastasectomy in patients with resected metastatic colorectal cancer. Curr Probl Cancer. 2024 Dec;53:101151.
• Kim SA, Jung M, Kim H, Byun JM, Hong J, Shin DY, Kim I, Yoon SS, Cho SY, Kyeong Hwang Y, Koh Y. MG4101, an allogeneic natural killer cell, in patients with relapsed or refractory acute myeloid leukemia: a pilot study. Leuk Lymphoma. 2024 Oct 22:1-8.
• Kim SA, Choi GH, Lee JY, Jang ES, Lee JO, Kim JW, Jeong SH, Bang SM. Apixaban for the treatment of acute splanchnic vein thrombosis: A pilot study. Thromb Res. 2024 May;237:181-183.
• Hyung J, Kang M, Kim I, Kim KP, Ryoo BY, Cheon J, Ryu H, Lee JS, Kim JW, Choi IS, Park JH, Abou-Alfa GK, Kim JW, Yoo C. Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-Analysis Based on Individual Patient-Level Data of Randomized Trials. Cancer Res Treat. 2024 Oct 17.
• Lee JY, Lee JH, Park W, Seo J, Kang M, Jung EH, Kim SA, Suh KJ, Kim JW, Kim SH, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM. The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients. Cancer Res Treat. 2024 Sep 20.
• Yoon D, Jeong HE, Choi S, Shin JY, Bang SM. Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort Study. Thromb Haemost. 2024 Feb;124(2):152-162.
• Han HS, Lee KW. Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer. J Gastric Cancer. 2024 Jan;24(1):4-28.
• Oh S, Nam SK, Lee KW, Lee HS, Park Y, Kwak Y, Lee KS, Kim JW, Kim JW, Kang M, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH. Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis. Cancer Res Treat. 2024 Jan;56(1):219-237.
• Lim SH, Lee KW, Kim JJ, Im HS, Kim IH, Han HS, Koo DH, Cho JH, Maeng CH, Lee MY, Lee HJ, Kim JH, Park SG, Jung JY, Shin SH, Kim KH, Kim H, Oh SY, Kang M, Jung M, Rha SY. Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06). BMC Cancer. 2024 Feb 23;24(1):252.
• Lee KW, Han SW, Kim TW, Ahn JB, Baek JY, Cho SH, Lee H, Kim JW, Kim JW, Kim TY, Hong YS, Beom SH, Cha Y, Choi Y, Kim S, Bang YJ. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer. Cancer Res Treat. 2024 Apr;56(2):590-601.
• Na HY, Kim JH, Kim H, Cho JY, Han HS, Jang ES, Kim JW, Jeong SH, Heo J, Kim JW, Kim JW, Ahn S. Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality. Histopathology. 2024 Jan;84(2):402-408.
• Kim M, Shim HS, Kim S, Lee IH, Kim J, Yoon S, Kim HD, Park I, Jeong JH, Yoo C, Cheon J, Kim IH, Lee J, Hong SH, Park S, Jung HA, Kim JW, Kim HJ, Cha Y, Lim SM, Kim HS, Lee CK, Kim JH, Chun SH, Yun J, Park SY, Lee HS, Cho YM, Nam SJ, Na K, Yoon SO, Lee A, Jang KT, Yun H, Lee S, Kim JH, Kim WS. Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP. J Pathol Transl Med. 2024 Jul;58(4):147-164.
• Choi S, Seo S, Lee JH, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Kim TW, Hong YS, Kim SY, Kim JE, Kim SW, Lee DH, Lee JC, Choi CM, Yoon S, Koh SJ, Min YJ, Ahn Y, Kim HJ, Baek JH, Park SR, Kim JH. Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study. Cancer Res Treat. 2024 Apr;56(2):404-413.
• Hong S, Lee JH, Heo JY, Suh KJ, Kim SH, Kim YJ, Kim JH. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data. J Cancer Res Clin Oncol. 2024 Apr 10;150(4):186.
• Kim SY, Kim JH, Kim TY, Park SR, Yoon S, Lee S, Lee SH, Kim TM, Han SW, Kim HR, Yun H, Lee S, Kim J, Choi YL, Choi KS, Chae H, Ryu H, Lee GW, Zang DY, Ahn JB. Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09. BMC Cancer. 2024 May 9;24(1):574.
• Kim TY, Kim SY, Kim JH, Jung HA, Choi YJ, Hwang IG, Cha Y, Lee GW, Lee YG, Kim TM, Lee SH, Lee S, Yun H, Choi YL, Yoon S, Han SW, Kim TY, Kim TW, Zang DY, Kang JH. Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05. ESMO Open. 2024 Oct;9(10):103709.
• Lee JO, Lee S, Lee D, Hwang T, Joe S, Yang JO, Jeong J, Ohn JH, Kim JH. KTED: a comprehensive web-based database for transposable elements in the Korean genome. Bioinform Adv. 2024 Nov 19;4(1):vbae179.
• Park SM, Kim YJ, Lee JY. Inconsistency in steroid use as antiemetics in clinical trial protocols involving immune checkpoint inhibitors combined with chemotherapy. Cancer Med. 2024 Apr;13(7):e7142.
• Kim YJ, Lee H, Woo HG, Lee SW, Hong M, Jung EH, Yoo SH, Lee J, Yon DK, Kang B. Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort. Sci Rep. 2024 May 20;14(1):11503.
• Suh KJ, Jung EH, Seo J, Ji SY, Hwang K, Han JH, Kim CY, Kim IA, Kim YJ. Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea. Oncologist. 2024 Nov 4;29(11):e1586-e1592.
• Kim YJ, Kim S, Kim TM, Suh KJ, Kim M, Kim SH, Keam B, Kim DW, Lee JS, Heo DS. A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19). Lung Cancer. 2024 Aug;194:107870.
• Jung EH, Hiratsuka Y, Suh SY, Yoon SJ, Kang B, Lee SW, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW, Kim YJ. Clinicians' Prediction of Survival Is Most Useful for Palliative Care Referral. Palliat Med Rep. 2024 Aug 21;5(1):365-372. doi: 10.1089/pmr.2024.0013.
• Jung EH, Yoo SH, Lee SW, Kang B, Kim YJ. Development of a Prediction Model for Delirium in Hospitalized Patients with Advanced Cancer. Cancer Res Treat. 2024 Oct;56(4):1277-1287.
• Lee JY, Kwon JH, Hur JY, Yi JH, Lee JH, Cho H, Do YR, Jo JC, Kang HJ, Koh Y, Lee WS, Lim SN, Yoon SE, Kim SJ, Lee JO. Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea. Cancer Res Treat. 2024 Apr;56(2):681-687.
• Lo Prinzi F, Salani F, Rimini M, Rizzato MD, Antonuzzo L, Camera S, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Melo Alvim C, Roque R, Fornaro L, De Rosa A, Lavacchi D, Rossari F, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Viola MG, Silvestro L, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Ahcene Djaballah S, Zanuso V, Masi G, Lonardi S, Rimassa L, Casadei-Gardini A. Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population. Oncologist. 2025 Mar 10;30(3):oyae256.
• Koh J, Kim J, Woo GU, Yi H, Kwon SY, Seo J, Bae JM, Kim JH, Won JK, Ryu HS, Jeon YK, Lee DW, Kim M, Kim TY, Lee KH, Kim TY, Lee JS, Seong MW, Kim S, Lee S, Yun H, Song MG, Choi J, Kim JI, Im SA. Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience. Cancer Res Treat. 2024 Aug 21.
• Lee CK, Yoo C, Hong JY, Park SJ, Kim JW, Kang M, Lee MA. Real-world study of systemic treatment after first-line atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries. Liver Cancer. 2024;1-15.
• Choi S, Kim SH, Lee S, Seo J, Kang M, Jung EH, Kim SA, Suh KJ, Lee JY, Kim JW, Kim JW, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. Association of TP53 Mutation Status and Sex with Clinical Outcome in NSCLC Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study. Cancer Res Treat. 2024 Aug 7.
• Rimini M, Fornaro L, Rizzato MD, Antonuzzo L, Rossari F, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Nichetti F, Chon HJ, Braconi C, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Salani F, De Rosa A, Lavacchi D, Foti S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Djaballah SA, Zanuso V, Masi G, Lonardi S, Rimassa L, Casadei-Gardini A. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population. Eur J Cancer. 2024 Jun 30;208:114199.
• Lim SH, Lee KW, Kim JJ, Im HS, Kim IH, Han HS, Koo DH, Cho JH, Maeng CH, Lee MY, Lee HJ, Kim JH, Park SG, Jung JY, Shin SH, Kim KH, Kim H, Oh SY, Kang M, Jung M, Rha SY. Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06). BMC Cancer. 2024 Feb 23;24(1):252.
• Kim DH, Kim S, Park S, Byun JM, Hong J, Shin DY, Kim I, Bang SM, Lee JO, Lee JY, Kim SA, Kim KH, Chung YJ, Jung SH, Koh Y, Yoon SS. Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome. Br J Haematol. 2024 Dec;205(6):2305-2314. doi: 10.1111/bjh.19828. Epub 2024 Oct 10.
• Fu W, Bang SM, Huang H, Kim K, Li W, An G, Lee JJ, Cai Z, Jin J, Wang Y, Chim CS, Carson R, Liu R, Zhao M, Chen X, Cui C, Hou J, Wang J. Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study. Ann Hematol. 2025 Jan;104(1):515-525.
• Shin HJ, Kim DY, Kim K, Min CK, Lee JJ, Mun YC, Lee WS, Lim SN, Kim JS, Moon JH, Kim DJ, Bang SM, Won JH, Jo JC, Koh YI. Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913). Cancer Res Treat. 2024 Jul;56(3):956-966.
• Hungria V, Robak P, Hus M, Zherebtsova V, Ward C, Ho PJ, Ribas de Almeida AC, Hajek R, Kim K, Grosicki S, Sia H, Bryant A, Pitombeira de Lacerda M, Aparecida Martinez G, Sureda Balarí AM, Sandhu I, Cerchione C, Ganly P, Dimopoulos M, Fu C, Garg M, Abdallah AO, Oriol A, Gatt ME, Cavo M, Rifkin R, Fujisaki T, Mielnik M, Pirooz N, McKeown A, McNamara S, Zhou X, Nichols M, Lewis E, Rogers R, Baig H, Eccersley L, Roy-Ghanta S, Opalinska J, Mateos MV; DREAMM-7 Investigators. Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2024 Aug 1;391(5):393-407.
• Byun JM, Shin J, Kim SA, Park H, Lee J, Shin DY, Hong J, Lee JO, Bang SM, Kim I, Yoon SS, Koh Y. A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients. Cancer Res Treat. 2024 Apr;56(2):675-680.
• Ninkovic S, Harrison SJ, Lee JJ, Murphy N, Lee JH, Estell J, Chen VM, Horvath N, Kim K, Eek R, Augustson B, Bang SM, Huang SY, Rajagopal R, Szabo F, Engeler D, Butcher BE, Mollee P, Durie B, Chng WJ, Quach H. Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study. Haematologica. 2024 Jul 1;109(7):2229-2238.
• Kim DH, Hong J, Shin DY, Kim I, Yoon SS, Bang SM, Lee JO, Lee JY, Kim SA, Byun JM, Koh Y. Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. Br J Haematol. 2024 Jul;205(1):356-359.
• Lee Y, Seo SH, Kim J, Kim SA, Lee JY, Lee JO, Bang SM, Park KU, Hwang SM. Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. Mol Diagn Ther. 2024 May;28(3):311-318.
• Kim KH, Lim SM, Ahn HK, Lee YG, Lee KW, Ahn MJ, Keam B, Kim HR, Lee HW, An HJ, Kim JS. A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. Cancer Res Treat. 2024 Jan;56(1):37-47.
• Shitara K, Fleitas T, Kawakami H, Curigliano G, Narita Y, Wang F, Wardhani SO, Basade M, Rha SY, Wan Zamaniah WI, Sacdalan DL, Ng M, Yeh KH, Sunpaweravong P, Sirachainan E, Chen MH, Yong WP, Peneyra JL, Ibtisam MN, Lee KW, Krishna V, Pribadi RR, Li J, Lui A, Yoshino T, Baba E, Nakayama I, Pentheroudakis G, Shoji H, Cervantes A, Ishioka C, Smyth E. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer. ESMO Open. 2024 Feb;9(2):102226.
• Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial. J Clin Oncol. 2024 Feb 10;42(5):507-517.
• Song DH, Kim N, Jo HH, Kim S, Choi Y, Oh HJ, Lee HS, Yoon H, Shin CM, Park YS, Lee DH, Kang SH, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Ahn S, Surh YJ. Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients. Gut Liver. 2024 Mar 15;18(2):231-244.
• Kang YK, Ryu MH, Di Bartolomeo M, Chau I, Yoon H, Kim JG, Lee KW, Oh SC, Takashima A, Kryzhanivska A, Chao Y, Evesque L, Schenker M, McGinn A, Zhao Y, Lee J, Wyrwicz L, Boku N. Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial. Gastric Cancer. 2024 Mar;27(2):375-386.
• Kim JH, Kim N, Song DH, Choi Y, Jeon EB, Kim S, Jun YK, Yoon H, Shin CM, Park YS, Lee DH, Oh HJ, Lee HS, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH, Ahn S. Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study. Gastric Cancer. 2024 Mar;27(2):221-234.
• Choi S, Seo S, Lee JH, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Kim TW, Hong YS, Kim SY, Kim JE, Kim SW, Lee DH, Lee JC, Choi CM, Yoon S, Koh SJ, Min YJ, Ahn Y, Kim HJ, Baek JH, Park SR, Kim JH. Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study. Cancer Res Treat. 2024 Apr;56(2):404-413.
• Qiu MZ, Oh DY, Kato K, Arkenau T, Tabernero J, Correa MC, Zimina AV, Bai Y, Shi J, Lee KW, Wang J, Poddubskaya E, Pan H, Rha SY, Zhang R, Hirano H, Spigel D, Yamaguchi K, Chao Y, Wyrwicz L, Disel U, Cid RP, Fornaro L, Evesque L, Wang H, Xu Y, Li J, Sheng T, Yang S, Li L, Moehler M, Xu RH; RATIONALE-305 Investigators. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial. BMJ. 2024 May 28;385:e078876.
• Wainberg ZA, Kang YK, Lee KW, Qin S, Yamaguchi K, Kim IH, Saeed A, Oh SC, Li J, Turk HM, Teixeira A, Hitre E, Udrea AA, Cardellino GG, Sanchez RG, Zahlten-Kümeli A, Taylor K, Enzinger PC. Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial. Gastric Cancer. 2024 May;27(3):558-570.
• Jung EH, Hiratsuka Y, Suh SY, Yoon SJ, Kang B, Lee SW, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW, Kim YJ. Clinicians' Prediction of Survival Is Most Useful for Palliative Care Referral. Palliat Med Rep. 2024 Aug 21;5(1):365-372.
• Kang YK, Qin S, Lee KW, Oh SC, Kim IH, Kim JG, Li Y, Yan Z, Li J, Bai LY, Chan C, Yusuf A, Zahlten-Kümeli A, Taylor K, Yamaguchi K. Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis. Gastric Cancer. 2024 Sep;27(5):1046-1057.
• Kim Y, Keam B, Kang EJ, Kim JS, Kim HR, Lee KW, Kwon JH, Lee KE, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Choi MY, Lee KH, Kim SB, Ahn MJ. Analysis of Response mand Progression Patterns of Tyrosine Kinhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials. Cancer Res Treat. 2024 Oct;56(4):1068-1076.
• Boku N, Omori T, Shitara K, Sakuramoto S, Yamaguchi K, Kato K, Kadowaki S, Tsuji K, Ryu MH, Oh DY, Oh SC, Rha SY, Lee KW, Chung IJ, Sym SJ, Chen LT, Chen JS, Bai LY, Nakada T, Hagihara S, Makino R, Nishiyama E, Kang YK. Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial. Gastric Cancer. 2024 Nov;27(6):1287-1301.
• Choi S, Kang M, Kim JW, Kim JW, Jeon JH, Oh HK, Lee HW, Cho JY, Kim DW, Cho S, Kim JH, Kim K, Kang SB, Jheon S, Lee KW. Long-term clinical outcomes after the second metastasectomy in patients with resected metastatic colorectal cancer. Curr Probl Cancer. 2024 Dec;53:101151.
• Cho SW, Keam B, Lee KW, Kim JW, Han DH, Kim HJ, Kim JW, Kim DY, Rhee CS, Bae YJ, Kim JH, Eom KY, Wu HG, Kim YH, Kim CY, Paek SH, Kim H, Won TB. Role of induction chemotherapy in advanced-stage olfactory neuroblastoma. Int Forum Allergy Rhinol. 2024 Dec;14(12):1882-1891.
• Baek SK, Jeong JH, Jung K, Ahn HK, Kim MH, Sohn J, Park IH, Ahn JS, Lee DW, Im SA, Sim SH, Lee KS, Hyun Kim J, Shim HJ, Chae Y, Koh SJ, Lee H, Lee J, Byun JH, Seol Y, Lee EM, Jee HJ, An H, Park EB, Suh YJ, Lee KE, Park YH; Korean Cancer Study Group (KCSG). A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15). Ther Adv Med Oncol. 2024 Jan 28;16:17588359231225029.
• Bai K, Woo JW, Kwon HJ, Chung YR, Suh KJ, Kim SH, Kim JH, Park SY. Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status. Lab Invest. 2024 Aug;104(8):102092.
• Woo JW, Han EK, Suh KJ, Kim SH, Kim JH, Park SY. Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer. Breast Cancer Res Treat. 2024 Sep;207(2):301-311.
• Mukohara T, Park YH, Sommerhalder D, Yonemori K, Hamilton E, Kim SB, Kim JH, Iwata H, Yamashita T, Layman RM, Mita M, Clay T, Chae YS, Oakman C, Yan F, Kim GM, Im SA, Lindeman GJ, Rugo HS, Liyanage M, Saul M, Le Corre C, Skoura A, Liu L, Li M, LoRusso PM. Inhibition of lysine acetyltransferase KAT6 in ER⁺HER2^- metastatic breast cancer: a phase 1 trial. Nat Med. 2024 Aug;30(8):2242-2250.
• Han EK, Woo JW, Suh KJ, Kim SH, Kim JH, Park SY. PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance. Cancer Res Treat. 2024 Apr;56(2):557-566.
• Lee DW, Jung KH, Lee KH, Park YH, Lee KS, Sohn J, Ahn HK, Jeong JH, Koh SJ, Kim JH, Kim HJ, Lee KE, Kim HJ, Yang YW, Park KH, Lee J, Won HS, Kim TY, Im SA. Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial. Eur J Cancer. 2024 Jan;197:113456.
• Ha H, Lee HY, Kim JH, Kim DY, An HJ, Bae S, Park HS, Kang JH. Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design. Cancer Res Treat. 2024 Oct;56(4):991-1013.
• Yao H, Yan M, Tong Z, Wu X, Ryu MH, Park JJ, Kim JH, Zhong Y, Zhao Y, Voskoboynik M, Yin Y, Liu K, Kaubisch A, Liu C, Zhang J, Wang S, Im SA, Ganju V, Barve M, Li H, Ye C, Roy AC, Bai LY, Yen CJ, Gu S, Lin YC, Wu L, Bao L, Zhao K, Shen Y, Rong S, Zhu X, Song E. Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial. J Clin Oncol. 2024 Oct 10;42(29):3453-3465.
• Iwata H, Xu B, Kim SB, Chung WP, Park YH, Kim MH, Tseng LM, Chung CF, Huang CS, Kim JH, Chiu JWY, Yamashita T, Li W, Egorov A, Nishijima S, Nakatani S, Nishiyama Y, Sugihara M, Cortés J, Im SA. Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancer. Cancer Sci. 2024 Sep;115(9):3079-3088.
• Lee JY, Lee JW, Chung MS, Choi JG, Sim SH, Kim HJ, Kim JE, Lee KE, Park YH, Kang MJ, Ahn MS, Chae YS, Park JH, Kim JH, Kim GM, Byun JH, Park KU, Kim JW, Jung SP, Lee JH, An JS, Jang B, Yoon D, Kim J, Hong J, Koo H, Cho KR, Kim CY, Sa JK, Park KH. Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers. BMC Med. 2024 Sep 27;22(1):422.
• Han E, Choi HY, Kwon HJ, Chung YR, Shin HC, Kim EK, Suh KJ, Kim SH, Kim JH, Park SY. Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer. Breast Cancer Res. 2024 Dec 6;26(1):180.
• Jeon EB, Kim N, Kim BJ, Hwang IC, Kim SB, Kim JH, Choi Y, Jun YK, Yoon H, Shin CM, Park YS, Lee DH, Ahn S. Risk of Ischemic Stroke in Relation to Helicobacter pylori Infection and Eradication Status: A Large-Scale Prospective Observational Cohort Study. Gut Liver. 2024 Jul 15;18(4):642-653.
• Park S, Kim YJ, Min YJ, Mortimer PGS, Kim HJ, Smith SA, Dean E, Jung HA, Sun JM, Park WY, Ahn JS, Ahn MJ, Lee SH, Park K. Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer. Cancer. 2024 Feb 15;130(4):541-552.
• Yoo SH, Kang J, Kim HJ, Lee SW, Hong M, Jung EH, Kim YJ, Yon DK, Kang B. Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study. Sci Rep. 2024 Mar 12;14(1):6004.
• Kim JW, Lee HJ, Lee JY, Park SR, Kim YJ, Hwang IG, Kyun Bae W, Byun JH, Kim JS, Kang EJ, Lee J, Shin SJ, Chang WJ, Kim EO, Sa JK, Park KH. Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). J Immunother Cancer. 2024 Mar 13;12(3):e008638.
• Hong S, Lee JH, Heo JY, Suh KJ, Kim SH, Kim YJ, Kim JH. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data. J Cancer Res Clin Oncol. 2024 Apr 10;150(4):186.
• Park S, Kim TM, Han JY, Lee GW, Shim BY, Lee YG, Kim SW, Kim IH, Lee S, Kim YJ, Park JH, Park SG, Lee KH, Kang EJ, Kim JW, Shin SH, Ock CY, Nam BH, Lee J, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ. Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04). J Clin Oncol. 2024 Apr 10;42(11):1241-1251.
• Bian DJH, Lazaratos AM, Maritan SM, Quaiattini A, Zeng Z, Zhu Z, Sener U, Malani R, Kim YJ, Ichihara E, Cohen V, Rose AAN, Bouganim N, Dankner M. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss. Heliyon. 2024 Apr 17;10(9):e29668.
• Lee DW, Lee SY, Yoo SH, Kim KH, Kim MS, Shin J, Hwang IY, Hwang IG, Baek SK, Kim DY, Kim YJ, Kang B, Lee J, Cho B. SupporTive Care At Home Research (STAHR) for patients with advanced cancer: Protocol for a cluster non-randomized controlled trial. PLoS One. 2024 May 13;19(5):e0302011.
• Kang E, Kang JH, Koh SJ, Kim YJ, Seo S, Kim JH, Cheon J, Kang EJ, Song EK, Nam EM, Oh HS, Choi HJ, Kwon JH, Bae WK, Lee JE, Jung KH, Yun YH. Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2024 Aug 1;7(8):e2426304.
• Park S, Baldry R, Jung HA, Sun JM, Lee SH, Ahn JS, Kim YJ, Lee Y, Kim DW, Kim SW, Lee KH, Lee WJ, Choi JW, Chong K, Lee JI, Gwon SH, Son NH, Ahn MJ. Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). J Clin Oncol. 2024 Aug 10;42(23):2747-2756.
• Felip E, Cho BC, Gutiérrez V, Alip A, Besse B, Lu S, Spira AI, Girard N, Califano R, Gadgeel SM, Yang JC, Yamamoto S, Azuma K, Kim YJ, Lee KH, Danchaivijitr P, Ferreira CG, Cheng Y, Sendur MAN, Chang GC, Wang CC, Prabhash K, Shinno Y, Stroyakovskiy D, Paz-Ares L, Rodriguez-Cid JR, Martin C, Campelo MRG, Hayashi H, Nguyen D, Tomasini P, Gottfried M, Dooms C, Passaro A, Schuler M, Gelatti ACZ, Owen S, Perdrizet K, Ou SI, Curtin JC, Zhang J, Gormley M, Sun T, Panchal A, Ennis M, Fennema E, Daksh M, Sethi S, Bauml JM, Lee SH. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA. Ann Oncol. 2024 Sep;35(9):805-816.
• Kang EJ, Yang Y, Lee S, Kim YJ, Lim SM, Ahn MJ, Choi YJ, Lee Y, Kim TM, Kim I, Ahn HK, Jeung HC, Lee SI, Oh SY, Bae WK, Ryu H, Park KH, Lee KH. A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17). ESMO Open. 2024 Sep;9(9):103668.
• Hong MH, Choi YJ, Ahn HK, Lim SM, Keam B, Kim DW, Kim TM, Youk J, Kim YJ, Hwang S, Kim S, Kim JW, Kim HR, Kang JH. Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Oct 1;10(10):1342-1351.
• Yun JY, Jung JY, Keam B, Lee NR, Kang JH, Kim YJ, Shim HJ, Jung KH, Koh SJ, Ryu H, Yoo SH, Kang E, Yun YH. Depression, performance status, and discontinued treatment mediate an association of curability belief with prognosis in advanced cancer patients. Sci Rep. 2024 Nov 24;14(1):29098.
• Kim HJ, Jung EH, Kwon JH, Kim YJ, Koh SJ, Lee MA, Kang JH, Rha SY, Nam EM, Baek SK, Lee HY, Song HH, Won YW, Lee H. Psychometric Validation of Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients. Cancer Res Treat. 2024 Dec 5.
• Suh KJ, Jung EH, Seo J, Ji SY, Hwang K, Han JH, Kim CY, Kim IA, Kim YJ. Current status of advance care planning, palliative care consultation, and end- of-life care in patients with glioblastoma in South Korea. Oncologist. 2024 Nov 4;29(11):e1586-e1592.

내분비내과

• Choi JW, Kong SH, Kim YJ, Chung HS, Yu JM, Park JS, Lee CH, Park JH, Kim DS, Oh CM, Moon S. Effect of low muscle mass on total mortality related to metabolic disease in chronic kidney disease patients. Sci Rep. 2024 Oct 1;14(1):22837. doi: 10.1038/s41598-024-73903-w. PMID: 39354032; PMCID: PMC11445479.
• Kong SH, Cho W, Park SB, Choo J, Kim JH, Kim SW, Shin CS. A Computed Tomography-Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study. J Med Internet Res. 2024 Jul 12;26:e48535. doi: 10.2196/48535. PMID: 38995678; PMCID: PMC11282387.
• Kong SH, Kim SW. Is cardiovascular evaluation necessary for elderly patients with primary hyperparathyroidism? Gland Surg. 2024 May 30;13(5):781-783. doi: 10.21037/gs-23-534. Epub 2024 May 16. PMID: 38845838; PMCID: PMC11150199.
• Kim Y, Kim YG, Park JW, Kim BW, Shin Y, Kong SH, Kim JH, Lee YK, Kim SW, Shin CS. A CT-based Deep Learning Model for Predicting Subsequent Fracture Risk in Patients with Hip Fracture. Radiology. 2024 Jan;310(1):e230614. doi: 10.1148/radiol.230614. PMID: 38289213.
• Kim MJ, Won H, Kim WB, et al. Comparison of Patient-Reported Outcomes Between Active Surveillance and Immediate Lobectomy in Patients with Low-Risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS Cohort. Thyroid 2024;34(11):1371-1378. DOI: 10.1089/thy.2024.0264.
• Choe HJ, Moon JH, Kim W, Koo BK, Cho NH. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up, Metabolism, 2024 Apr:153:155800
• Choi W, Moon JH, Choi H, Lee H, Kim HK, Kang HC, Cho NH. Trajectory of Lung Function in Diabetic Adults: A 16-year Follow-up Study of Community-based Prospective Cohorts, Respirology, 2024 May;29(5):413-420
• Moon JH, Choe HJ, Lim S. Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, J Diabetes Investig, 2024 Jun;15(6):669-684
• Jang HN, Park YS, Moon JH, Choi SH, Jang HC, Oh TJ. Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity. J Diabetes Investig. 2024 Dec;15(12):1773-1780. doi: 10.1111/jdi.14332. Online ahead of print. PMID: 39412383
• Shin, K. et al. A preliminary evaluation of the diagnostic performance of a smartphone-based machine learning-assisted system for evaluation of clinical activity score in digital images of thyroid-associated orbitopathy. Thyroid 0, (2024).
• Kim, M. J. et al. Comparison of Patient Reported Outcomes between Active surveillance and Immediate Lobectomy in Patients with Low-risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS cohort. Thyroid 0, (2024).
• Kim, J., Shin, J., Kim, M. S. & Moon, J. H. Cost-Effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism. J. Clin. Endocrinol. Metab. dgae751 (2024) doi:10.1210/clinem/dgae751.
• Choe HJ, Chang W, Blüher M, Heymsfield SB, Lim S. Independent association of thigh muscle fat density with vascular events in Korean adults. Cardiovasc Diabetol. 2024 Jan 28;23(1):44. PMID: 38281946
• Choe HJ, Oh HR, Bu D, An N, Scherer PE, An Z, Lim S. Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location-F study. Diabetes Obes Metab. 2024 Mar;26(3):1114-1119. PMID: 38073421
• Sohn M, Lim S. The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis. Int J Mol Sci. 2024 Feb 23;25(5):2593. PMID: 38473840
• Lim S, Lee SH, Min KW, Lee CB, Kim SY, Yoo HJ, Kim NH, Kim JH, Oh S, Won JC, Kwon HS, Kim MK, Park JH, Jeong IK, Kim S. A Multicenter, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin. Diabetes Obes Metab. 2024 Jun;26(6):2188-2198. PMID: 38425186
• Moon JH, Choe HJ, Lim S. Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. J Diabetes Investig. 2024 Jun;15(6):669-683. PMID: 38676410
• Sohn M, Nam S, Nauck MA, Lim S. Long-term comparison of renal and metabolic outcomes after sodium–glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC Med. 2024 Jul 2;22(1):273. PMID: 38956548
• Huh Y, Park KY, Han K, Jung JH, Cho YJ, Park HS, Nam GE, Lim S. Association between glycemic status and all-cause mortality among individuals with dementia: a nationwide cohort study. Alzheimer's Research & Therapy 2024 Aug 22;16(1):191. PMID: 39175087
• Lim S, Bae JH (co-first author), Oh H, Hwang IC, Yoon YE, Cho GY. Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial. Cardiovasc Diabetol. 2024 Oct 22;23(1):373. PMID: 39438942
• Neeland IJ, Lim S (co-corresponding author), Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, Powell-Wiley TM, Després JP (co-corresponding author). The Metabolic Syndrome. Nat Rev Dis Primers 2024 Oct 17;10(1):77. PMID: 39420195
• Lim S, Sohn M, Nauck MA. Cardiovascular outcome with SGLT2i and GLP1RA. Eur J Intern Med. 2024 Nov:129:133-136. PMID: 38849275
• Hae Jin Kim, Kyu Yeon Hur, Yong-Ho Lee, Jin Taek Kim, Yong-Kyu Lee, Ki-Hyun Baek, Euy Jin Choi, Won Min Hwang, Ki Tae Bang, Jung Soo Lim, Yun Jae Chung, Sung Rae Jo, Joon Seok Oh, Soon Hee Lee, Seung-Hyun Ko, Sung Hee Choi. Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study. Adv Ther. 2024 Aug;41(8):3119-3137
• Ha YJ, Lee JI, Choi SR, et al. Implications of thyroid-related autoantibodies in patients with Sjogren's syndrome without overt thyroid diseases. Clin Exp Rheumatol. 2024;42(12):2404-2411. DOI: 10.55563/clinexprheumatol/b3035x.
• Cho NH, Choi S, Kim MJ, et al. Distribution of urinary trace element exposure and dietary sources in women over 50 in an agricultural region- A community-based KoGES cohort study. Environ Res. 2024;252(Pt 3):118973. DOI: 10.1016/j.envres.2024.118973.
• Lee H, Song H, Choi SY, et al. Impact of clonal haematopoiesis on atherosclerotic cardiovascular disease according to low-density lipoprotein cholesterol levels in general population. Eur J Prev Cardiol. 2024;31(9):1162-1171. DOI: 10.1093/eurjpc/zwae055.
• Nam Y, Park S, Kim E, et al. Blood Pb levels are associated with prostate cancer prevalence among general adult males: Linking National Cancer Registry (2002-2017) and KNHANES (2008-2017) databases of Korea. Int J Hyg Environ Health. 2024;256:114318. DOI: 10.1016/j.ijheh.2023.114318.
• Lee I, Kim MJ, Choi S, Park YJ, Park J, Ayaz GN, Lee G, Cho YH, Jeon HL, Lee C, Cheon GJ, Moon MK, Choi K. Gender- and Age-Group Specific Association of Persistent Organic Pollutants (POPs) Exposure with Diabetes Mellitus: Korean National Environmental Health Survey (KoNEHS) 2015-2017. Environ Health (Wash). 2024 Mar 15;2(5):322-331.
• Nam Y, Park S, Kim E, et al. Blood Pb levels are associated with prostate cancer prevalence among general adult males: Linking National Cancer Registry (2002-2017) and KNHANES (2008-2017) databases of Korea. Int J Hyg Environ Health. 2024;256:114318. DOI: 10.1016/j.ijheh.2023.114318.
• Lee I, Kim MJ, Choi S, Park YJ, Park J, Ayaz GN, Lee G, Cho YH, Jeon HL, Lee C, Cheon GJ, Moon MK, Choi K. Gender- and Age-Group Specific Association of Persistent Organic Pollutants (POPs) Exposure with Diabetes Mellitus: Korean National Environmental Health Survey (KoNEHS) 2015-2017. Environ Health (Wash). 2024 Mar 15;2(5):322-331.
• Jang HN, Park YS, Moon JH, Choi SH, Jang HC, Oh TJ. Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity. J Diabetes Investig. 2024 Dec;15(12):1773-1780. doi: 10.1111/jdi.14332. Online ahead of print. PMID: 39412383
• Kumagai H, Kim SJ, Miller B, Zempo H, Tanisawa K, Natsume T, Lee SH, Wan J, Leelaprachakul N, Kumagai ME, Ramirez R 2nd, Mehta HH, Cao K, Oh TJ, Wohlschlegel JA, Sha J, Nishida Y, Fuku N, Dobashi S, Miyamoto-Mikami E, Takaragawa M, Fuku M, Yoshihara T, Naito H, Kawakami R, Torii S, Midorikawa T, Oka K, Hara M, Iwasaka C, Yamada Y, Higaki Y, Tanaka K, Yen K, Cohen P. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience. 2024 Oct 19;27(11):111212. doi: 10.1016/j.isci.2024.111212. eCollection 2024 Nov 15. PMID: 39559755
• Lee, H. K., Kim, N. E., Shin, C. M., Oh, T. J., Yoon, H., Park, Y. S., Kim, N., Won, S. & Lee, D. H. Gut microbiome signature of metabolically healthy obese individuals according to anthropometric, metabolic and inflammatory parameters. Sci Rep. 2024 Feb 11;14(1):3449. PMID: 38342934
• Yi, Y., Kwon, E. J., Yun, G., Park, S., Jeong, J. C., Na, K. Y., Chin, H. J., Yoo, S., Kim, S., Oh, T. J. & Kim, S. Impact of metformin on cardiovascular and kidney outcome based on kidney function status in type 2 diabetic patients: a multicentric, retrospective cohort study. Sci Rep. 2024 Jan 24;14(1):2081. PMID: 38267451
• Oh, D. et al. Artificial intelligence-based CT-free quantitative thyroid SPECT for thyrotoxicosis: study protocol of a multicentre, prospective, non-inferiority study. BMJ Open 14, e089552 (2024).
• Kim, M. J. et al. A national survey of physicians regarding active surveillance for low-risk thyroid cancer in Korea. Eur. Thyroid J. (2024) doi:10.1530/etj-24-0281.
• Lee BW, Cho YM, Kim SG, Ko SH, Lim S, Dahaoui A, Jeong JS, Lim HJ, Yu JM. Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-On in a Korean Population With Type 2 Diabetes. Diabetes Ther. 2024 Feb;15(2):547-563. PMID: 38236431
• Kim I, Cho HJ, Lim S, Seok SH, Lee HY. Author Correction: Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. Exp Mol Med. 2024 Feb;56(1):250. PMID: 38225341
• Jang HJ, Kim YJ, Lee DH, Joo SK, Koo BK, Lim S, Lee WJ, Kim W. Differential Class Effects of Oral Anti-diabetic Drugs on Nonalcoholic Fatty Liver Disease. JAMA Intern Med. 2024 Feb 12:e238029. PMID: 38345802.
• Kim JY, Jin SM, Sim KH, Kim BY, Cho JH, Moon JS, Lim S, Kang ES, Park CY, Kim SG, Kim JH. Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial. Diabetologia. 2024 Jul;67(7):1223-1234. PMID: 38639876
• Jeong SI, Ban MS, Hwang JG, Park MK, Lim S, Kim S, Kwon SK, Kim Y, Cho JM, Na JJ, Huh W, Chung JY. The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes Obes Metab. 2024 Jul;26(7):2588-2597. PMID: 38618974
• An JH, Choi HS, Choi JS, Lim HW, Huh W, Oh YI, Park JS, Han J, Lim S, Lim CY, Kim TH, Moon JB, Youn HY. Effect of the sodium-glucose cotransporter-2 inhibitor, DWP16001, as an add-on therapy to insulin for diabetic dogs: A pilot study. Vet Med Sci. 2024 May;10(3):e1454. doi: 10.1002/vms3.1454.
• Kim NH, Moon JS, Lee YH, Cho HC, Kwak SH, Lim S, Moon MK, Kim DL, Kim TH, Ko E, Lee J, Kim SG. Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial. Diabetes Obes Metab. 2024 Sep;26(9):3642-3652. PMID: 38853720
• Cho YK, Kim KS, Lee BW, Hong JH, Yu JM, Lim S, Kim YA, Lee CB, Kim SS, Kwak SH, Lee WJ. Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-Controlled Study. Clin Ther. 2024 Sep;46(9):662-669. PMID: 39068060
• Krentz A, Jacob S, Heiss C, Sattar N, Lim S, Khunti K, Eckel RH. Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis. Atherosclerosis. 2024 Sep;396:118528. PMID: 39154392
• Kwak SH, Han KA, Kim ES, Choi SH, Won JC, Yu JM, Oh S, Yoo HJ, Kim CH, KimKS, Chun S, Kim YH, Cho SA, Kim DH, Park KS. Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of aPhase 3 randomized controlled trial. Diabetes Obes Metab. 2024 Oct;26(10):4203-4212. doi: 10.1111/dom.15738. Epub 2024 Jul 26. PMID: 39054871.
• Jang HN, Park YS, Moon JH, Choi SH, Jang HC, Oh TJ. Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity. J Diabetes Investig. 2024 Dec;15(12):1773-1780. doi: 10.1111/jdi.14332. Online ahead of print. PMID: 39412383
• Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study, Diabetes Obes Metab. 2024 Sep;26(9):3743-3752
• Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice, Diabetes Metab J. 2024 May;48(3):405-417
• A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study), J Diabetes Res 2024 Jan 5:2024:8915591.

신장내과

• Cho JM, Kwon S, Yang S, Park J, Jeong S, Park S, Ryu J, Kim S, Lee J, Lee JP, Yoon HJ, Kim DK, Joo KW, Kim YS, Kim K, Park M, Lee H. Acute kidney injury after non-cardiac major surgery: has it reduced? Clin Kidney J. 2024 Jun 19;17(7):sfae183. doi: 10.1093/ckj/sfae183. PMID: 39831175; PMCID: PMC11739792.
• Ha J, Jeong JC, Ryu JH, Kim MG, Huh KH, Lee KW, Jung HY, Kang KP, Ro H, Han S, Seok Kim B, Yang J; KNOW-KT Study Group. Impact of Arterial Calcification on Cardiovascular and Renal Outcomes in Kidney Transplant Patients. Kidney Dis (Basel). 2024 Apr 16;10(4):249-261. doi: 10.1159/000538929. PMID: 39131884; PMCID: PMC11309755.
• Hariharan S, Rogers N, Naesens M, Pestana JM, Ferreira GF, Requião-Moura LR, Foresto RD, Kim SJ, Sullivan K, Helanterä I, Goutaudier V, Loupy A, Kute VB, Cardillo M, Tanabe K, Åsberg A, Jensen T, Mahillo B, Jeong JC, Anantharaman V, Callaghan C, Ravanan R, Manas D, Israni AK, Mehta RB. Long-term Kidney Transplant Survival Across the Globe. Transplantation. 2024 Sep 1;108(9):e254-e263. doi: 10.1097/TP.0000000000004977. Epub 2024 Mar 19. PMID: 38499511.
• Jeong JC, Gelman AE, Chong AS. Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction. Curr Opin Organ Transplant. 2024 Dec 1;29(6):412-419. doi: 10.1097/MOT.0000000000001175. Epub 2024 Oct 16. PMID: 39422603; PMCID: PMC11537820.
• Jeong SI, Ban MS, Hwang JG, Park MK, Lim S, Kim S, Kwon SK, Kim Y, Cho JM, Na JJ, Huh W, Chung JY. The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes. Diabetes Obes Metab. 2024 Jul;26(7):2588-2597. doi: 10.1111/dom.15573. Epub 2024 Apr 15. PMID: 38618974.
• Kang C, Yun D, Yoon H, Hong M, Hwang J, Shin HM, Park S, Cheon S, Han D, Moon KC, Kim HY, Choi EY, Lee EY, Kim MH, Jeong CW, Kwak C, Kim DK, Oh KH, Joo KW, Lee DS, Kim YS, Han SS. Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activity. Kidney Int. 2024 May;105(5):997-1019. doi: 10.1016/j.kint.2024.01.011. Epub 2024 Feb 5. PMID: 38320721.
• Kim B, Yan JJ, Kang TK, Lee WB, Jeong JC, Yang J. Molecular incompatibility between pig CD200 and human CD200 receptor in in vitro xenogeneic immune responses. Xenotransplantation. 2024 May-Jun;31(3):e12863. doi: 10.1111/xen.12863. PMID: 38751087.
• Kim DH, Park HS, Bang JS, Shin HJ, Yoon BJ, Kim S, Jeong JC, Park S, Lee T. Routine Ureteral Stenting in Kidney Transplant Reduces Postoperative Hydronephrosis and Percutaneous Ureteral Interventions: A Single-Center Experience. Exp Clin Transplant. 2024 Jan;22(1):9-16. doi: 10.6002/ect.2023.0349. PMID: 38284370.
• Kim E, Huh H, Mo Y, Park JY, Jung J, Lee H, Kim S, Kim DK, Kim YS, Lim CS, Lee JP, Kim YC, Kim H. Long-term ozone exposure and mortality in patients with chronic kidney disease: a large cohort study. BMC Nephrol. 2024 Feb 28;25(1):74. doi: 10.1186/s12882-024-03500-6. PMID: 38418953; PMCID: PMC10900590.
• Kim SE, Jung SH, Yang J, Kim H, Lee KB, Kim J, Jeong JC, Jung JY, Han SH, Oh KH, Hyun YY. Association between urine creatinine excretion and bone mineral density in chronic kidney disease: Results from the KNOW-CKD study. J Nephrol. 2025 Jan;38(1):189-196. doi: 10.1007/s40620-024-02123-2. Epub 2024 Oct 29. PMID: 39472382.
• Kim SY, Choi YY, Kwon EJ, Seo S, Kim WY, Park SH, Park S, Chin HJ, Na KY, Kim S. Characterizing Glomerular Barrier Dysfunction with Patient-Derived Serum in Glomerulus-on-a-Chip Models: Unveiling New Insights into Glomerulonephritis. Int J Mol Sci. 2024 May 8;25(10):5121. doi: 10.3390/ijms25105121. PMID: 38791159; PMCID: PMC11121116.
• Ko A, Oh S, Byon JY, Weon B, Lee J, Lee W, Oh YK, Kim DK, Kim S, Kim YS, Lim CS, Lee JP. Surviving the cold: Assessing long-term outcomes among Korean CKD patients exposed to low perceived temperature during winter. Environ Res. 2024 Nov 15;261:119636. doi: 10.1016/j.envres.2024.119636. Epub 2024 Jul 17. PMID: 39029731.
• Kwon EJ, Choi Y, Kim SY, Park S, Yun G, Min SH, Kim S. Development of Drug Efficacy Testing Platform for Glomerulonephritis. Micromachines (Basel). 2024 Feb 24;15(3):317. doi: 10.3390/mi15030317. PMID: 38542564; PMCID: PMC10971927.
• Lee J, Lee J, Kim K, Lee J, Jung Y, Hyeon JS, Seo A, Jin W, Weon B, Shin N, Kim S, Lim CS, Kim YS, Lee JP, Hwang GS, Yang SH. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney Int. 2024 Jun;105(6):1239-1253. doi: 10.1016/j.kint.2024.01.040. Epub 2024 Feb 29. PMID: 38431216.
• Lee J, Oh S, Byon JY, Lee W, Weon B, Ko A, Jin W, Kim DK, Kim S, Oh YK, Kim YS, Lim CS, Lee JP. Long-term exposure to high perceived temperature and risk of mortality among patients with chronic kidney disease. Heliyon. 2024 Jan 24;10(3):e25222. doi: 10.1016/j.heliyon.2024.e25222. PMID: 38322898; PMCID: PMC10844275.
• Lim JH, Kwon S, Seo YJ, Kim YH, Kwon H, Kim YS, Lee H, Kim YL, Kim CD, Park SH, Hwang D, Yun WS, Kim HK, Huh S, Lee JS, Yoo KD, Jeong JC, Lee J, Lee JP, Cho JH. Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study. Kidney Int Rep. 2024 May 25;9(8):2474-2483. doi: 10.1016/j.ekir.2024.05.022. PMID: 39156155; PMCID: PMC11328785.
• Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Park SK, Lee KB, Jung JY, Jeong JC, Oh KH, Kang SW, Han SH; KNOW-CKD (KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease) Investigators. Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study. Atherosclerosis. 2024 Aug;395:117563. doi: 10.1016/j.atherosclerosis.2024.117563. Epub 2024 Apr 23. PMID: 38692977.
• Park H, Lee H, Baik S, Kim MS, Yang J, Jeong JC, Koo TY, Kim DG, Lee JM. Kidney Transplantation From Brain-Dead Donors With Hepatitis B or C in South Korea: A 2015 to 2020 Korean Organ Transplantation Registry Data Analysis. Transplant Proc. 2024 Jan-Feb;56(1):1-9. doi: 10.1016/j.transproceed.2023.11.006. Epub 2024 Jan 19. PMID: 38245494.
• Park H, Lee H, Baik S, Kim MS, Yang J, Jeong JC, Koo TY, Kim DG, Lee JM. Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ Transplantation Registry Data Analysis. Ann Transplant. 2024 May 21;29:e943588. doi: 10.12659/AOT.943588. PMID: 38769724; PMCID: PMC11127609.
• Ryu J, Kim S, Lim Y, Ohn JH, Kim SW, Cho JH, Park HS, Lee J, Kim ES, Kim NH, Song JE, Kim SH, Suh EC, Mukhtorov D, Park JH, Kim SK, Kim HW. Sodium Intake Estimation in Hospital Patients Using AI-Based Imaging: Prospective Pilot Study. JMIR Form Res. 2024 Feb 16;8:e48690. doi: 10.2196/48690. PMID: 38363594; PMCID: PMC10907947.
• Suh SH, Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Oh KH, Lee KB, Jeong JC, Jung JY, Kim SW; Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) Investigators. Circulating osteoprotegerin levels and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: results from the KNOW-CKD study. Sci Rep. 2024 Feb 19;14(1):4136. doi: 10.1038/s41598-024-54335-y. PMID: 38374135; PMCID: PMC10876961.
• Yi J, Kim SH, Lee H, Chin HJ, Park JY, Jung J, Song J, Kwak N, Ryu J, Kim S. Air quality and kidney health: Assessing the effects of PM₁₀, PM_2.5, CO, and NO₂ on renal function in primary glomerulonephritis. Ecotoxicol Environ Saf. 2024 Aug;281:116593. doi: 10.1016/j.ecoenv.2024.116593. Epub 2024 Jun 24. PMID: 38917585.
• Yi Y, Kwon EJ, Yun G, Park S, Jeong JC, Na KY, Chin HJ, Yoo S, Kim S, Oh TJ, Kim S, Jung CH, Lee H. Author Correction: Impact of metformin on cardiovascular and kidney outcome based on kidney function status in type 2 diabetic patients: a multicentric, retrospective cohort study. Sci Rep. 2024 May 29;14(1):12337. doi: 10.1038/s41598-024-62989-x. Erratum for: Sci Rep. 2024 Jan 24;14(1):2081. doi: 10.1038/s41598-024-52078-4. PMID: 38811668; PMCID: PMC11137128.
• An JN, Oh HJ, Oh S, Rhee H, Seong EY, Baek SH, Ahn SY, Cho JH, Lee JP, Kim DK, Ryu DR, Ahn S, Kim S. Bioimpedance-Guided Fluid Removal in Continuous KRT: The VENUS Randomized Clinical Trial. Clin J Am Soc Nephrol. 2024 Dec 1;19(12):1527-1536. doi: 10.2215/CJN.0000000000000557. Epub 2024 Sep 12. PMID: 39264719; PMCID: PMC11637699.
• Tran TT, Yun G, Kim S. Artificial intelligence and predictive models for early detection of acute kidney injury: transforming clinical practice. BMC Nephrol. 2024 Oct 16;25(1):353. doi: 10.1186/s12882-024-03793-7. PMID: 39415082; PMCID: PMC11484428.

알레르기내과

• An J, Lee H, Lee J, Kang SY, Yang MS, Song WJ, Kim SH, Kim TB. Prescription patterns and symptom relief of antitussives and expectorants in patients with cough: a nationwide study in Korea. J Thorac Dis. 2024 Sep 30;16(9):6150-6160. doi: 10.21037/jtd-23-1744. Epub 2024 Sep 3. PMID: 39444876; PMCID: PMC11494547.
• Kim J, Kim JS, Kim SH, Yoo S, Lee JK, Kim K. Deep learning-based prediction of Clostridioides difficile infection caused by antibiotics using longitudinal electronic health records. NPJ Digit Med. 2024 Aug 24;7(1):224. doi: 10.1038/s41746-024-01215-4. PMID: 39181992; PMCID: PMC11344761.
• Kim MY, Won HK, Oh JY, Lee JH, Jo EJ, Kang SY, Lee JH, Lee SE, Kang N, Kim YC, Lee HY, An J, Yoo Y, Shim JS, Park SY, Park HK, Kim MH, Kim SH, Kim SH, Chang YS, Kim SH, Lee BJ, Birring SS, Song WJ. Could cough hypersensitivity symptom profile differentiate phenotypes of chronic cough? ERJ Open Res. 2024 Nov 11;10(6):00260-2024. doi: 10.1183/23120541.00260-2024. PMID: 39534772; PMCID: PMC11551855.
• Lee JH, Kang SY, Yu I, Park KE, Oh JY, Lee JH, Park SY, Kim MH, Jo EJ, Moon JY, Kim SH, Kim SH, Lee BJ, Song WJ; Korean Academy of Asthma Allergy, Clinical Immunology Working Group on Chronic Cough. Cough Response to High-Dose Inhaled Corticosteroids in Patients with Chronic Cough and Fractional Exhaled Nitric Oxide Levels ≥ 25 ppb: A Prospective Study. Lung. 2024 Jun;202(3):275-280. doi: 10.1007/s00408-024-00698-y. Epub 2024 May 11. PMID: 38733542.
• Oh JY, Kang SY, Kang N, Won HK, Jo EJ, Lee SE, Lee JH, Shim JS, Kim YC, Yoo Y, An J, Lee HY, Park SY, Kim MY, Lee JH, Kim BK, Park HK, Kim MH, Kim SH, Kim SH, Chang YS, Kim SH, Lee BJ, Chung KF, Cho SH, Song WJ; Korean Chronic Cough Registry Study Group. Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study. Lung. 2024 Apr;202(2):97-106. doi: 10.1007/s00408-024-00674-6. Epub 2024 Feb 27. PMID: 38411774.
• Park JY, Jun H, Lee SE, Won HK, Kang SY, Kang N, Oh JY, Kim YC, Park SY, An J, Yoo Y, Kim MY, Lee HY, Shim JS, Kim MH, Kim SH, Kim SH, Chang YS, Kim SH, Lee BJ, Birring SS, Song WJ. Exploring the concept of disease control in chronic cough. ERJ Open Res. 2024 Sep 30;10(5):00320-2024. doi: 10.1183/23120541.00320-2024. PMID: 39351387; PMCID: PMC11440400.
• Park SY, Park SY, Seo S, Kwon HS, Kim SH, Kim SH, Park HK, Chang YS, Kim CW, Lee BJ, Park HS, Cho YS, Oh HB, Ostrov DA, Won S, Kim TB. HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity. World Allergy Organ J. 2024 Apr 13;17(5):100901. doi: 10.1016/j.waojou.2024.100901. PMID: 38638799; PMCID: PMC11021981.
• Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Adcock I, Bhavsar P, Chung KF, Kim TB. Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study. Ann Allergy Asthma Immunol. 2024 Apr;132(4):457-462.e2. doi: 10.1016/j.anai.2023.11.005. Epub 2023 Nov 17. PMID: 37977324.
• Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Bhavsar P, Adcock I, Chung KF, Kim TB. Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type 2-Biologics in the PRISM Study. Lung. 2024 Feb;202(1):41-51. doi: 10.1007/s00408-024-00670-w. Epub 2024 Jan 22. PMID: 38252134.
• Pham DD, Lee JH, Kwon HS, Song WJ, Cho YS, Kim H, Kwon JW, Park SY, Kim S, Hur GY, Kim BK, Nam YH, Yang MS, Kim MY, Kim SH, Lee BJ, Lee T, Park SY, Kim MH, Cho YJ, Park C, Jung JW, Park HK, Kim JH, Moon JY, Bhavsar P, Adcock IM, Chung KF, Kim TB. Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment. World Allergy Organ J. 2024 Nov 21;17(12):101000. doi: 10.1016/j.waojou.2024.101000. PMID: 39640896; PMCID: PMC11617764.
• Rhyou HI, Kim HK, Song WJ, Lee SM, Kim SH, Kwon JW, Park HK, Park HK, Kim SH, Choi JH, Kim S, Park SY, Kim SH, Moon JY, Jung JW, Cho YJ, Park CS, Kim BK, Kim JH, Yang MS, Kim MH, Nam YH, Lee T, Lee BJ, Bhavsar P, Adcock IM, Chung KF, Kim TB. Effect of biologic therapies on quality of life in severe asthma: Findings from the PRISM study. World Allergy Organ J. 2024 Aug 20;17(9):100957. doi: 10.1016/j.waojou.2024.100957. PMID: 39252792; PMCID: PMC11382106.
• Ye YM, Park JW, Kim SH, Cho YS, Lee SY, Lee SY, Sim S, Song E, Kim B, Lee J, Kim SK, Jang MH, Park HS. Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgE_Trap-Fc protein in subjects with Atopy: Results from the First-in-Human study. Int Immunopharmacol. 2024 Mar 30;130:111706. doi: 10.1016/j.intimp.2024.111706. Epub 2024 Feb 20. PMID: 38382265.

감염내과

• Lee CM, Lee S, Kim ES, Kim HB, Park WB, Moon SM, Kim YK, Park KH, Kwak YG, Kim B, Kim YS, Kim CJ, Gil HY, Ahn J, Song KH. Disease burden of bacteraemia with extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in Korea. J Hosp Infect. 2024 Feb;144:85-93. doi: 10.1016/j.jhin.2023.11.013. Epub 2023 Dec 10. PubMed PMID: 38072088.
• Ham SY, Chun JY, Song KH, Kang CK, Park JS, Jo HB, Ryu CM, Choi Y, Choi SJ, Lee E, Choe PG, Moon SM, Park WB, Bang J, Park SW, Park KU, Kim NJ, Oh MD, Kim ES, Kim HB. Limited impact of bacterial virulence on early mortality risk factors in Acinetobacter baumannii bacteremia observed in a Galleria mellonella model. Sci Rep. 2024 Jun 28;14(1):14960. doi: 10.1038/s41598-024-65940-2. PubMed PMID: 38942780; PubMed Central PMCID: PMC11213897.
• Song MJ, Kang M, Song KH, Kim HB, Kim ES, Jung J, Lim SY. Comparison of the risk of pneumothorax in COVID-19 and seasonal influenza. Sci Rep. 2024 Sep 10;14(1):21077. doi: 10.1038/s41598-024-69266-x. PubMed PMID: 39256438; PubMed Central PMCID: PMC11387474.
• Lee CM, Choi Y, Choi SJ, Moon SM, Kim ES, Kim HB, Ham SY, Park JS, Yeom J, Song KH. The Microbiological Characteristics of Acinetobacter Baumannii Associated With Early Mortality in Patients With Bloodstream Infection. Open Forum Infect Dis. 2024 Jul;11(7):ofae348. doi: 10.1093/ofid/ofae348. eCollection 2024 Jul. PubMed PMID: 39006316; PubMed Central PMCID: PMC11245698.
• Kim NH, Han K, Ji E, Ahn S, Choi Y, Choi SJ, Moon SM, Song KH, Kim ES, Kim HB. Trends of antibiotic use at the end-of-life of cancer and non-cancer decedents: a nationwide population-based longitudinal study (2006-2018). Antimicrob Steward Healthc Epidemiol. 2024;4(1):e83. doi: 10.1017/ash.2024.75. eCollection 2024. PubMed PMID: 38751939; PubMed Central PMCID: PMC11094383.
• Shin DW, Cho J, Choi KS, Lee J, Choi Y, Choi SJ, Kim SA, Moon SM, Kim ES, Kim HB, Park KU, Hong YJ, Song KH. False-positive results of galactomannan assays in patients administered glucose-containing solutions. Sci Rep. 2024 Jan 31;14(1):2552. doi: 10.1038/s41598-024-53116-x. PubMed PMID: 38291146; PubMed Central PMCID: PMC10827775.
• Shin SM, Lee Y, Heo E, Kim HS, Jeong YM, Lee J, Lee EE, Lee JY, Choi Y, Choi SJ, Moon SM, Song KH, Kim HB, Kim ES. Prescription of oral antibiotics and its appropriateness for outpatients in a tertiary care hospital in Korea. J Hosp Infect. 2024 Nov;153:81-89. doi: 10.1016/j.jhin.2024.09.009. Epub 2024 Sep 26. PubMed PMID: 39341283.
• Lee M, Choi Y, Choi SJ, Moon SM, Kim ES, Kim HB, Ahn S, Lee H, Kim J, Shin DW, Yeom J, Park JS, Song K-H. Staphylococcus argenteus bacteremia in the Republic of Korea. Microbiol Spectr. 2024 Feb 6;12(2):e0279823. doi: 10.1128/spectrum.02798-23. Epub 2024 Jan 10. PubMed PMID: 38197655; PubMed Central PMCID: PMC10846198.
• Lee KY, Song KH, Lee KH, Baek JY, Kim ES, Song YG, Kim YC, Park YS, Ahn JY, Choi JY, Choi WS, Bae S, Kim SW, Kwon KT, Kang ES, Peck KR, Kim SH, Jeong HW, Ko JH. Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection. Vaccine. 2024 Jul 25;42(19):3953-3960. doi: 10.1016/j.vaccine.2024.05.003. Epub 2024 May 9. PMID: 38729909.
• Moon SM, Kim B, Kim HB. Quantitative and qualitative evaluation of antimicrobial usage: the first step for antimicrobial stewardship. Korean J Intern Med. 2024 May;39(3):383-398. doi: 10.3904/kjim.2023.506. Epub 2024 Apr 30. PubMed PMID: 38715229; PubMed Central PMCID: PMC11076899.
• Jin Choi S, Lee W, Cheol Kim S, Jo HY, Park HY, Bin Kim H, Park WY, Ho Park S, Ko JH, Seok Lee J. Longitudinal multiomic profiling and corticosteroid modulation of the immediate innate immune response to an adenovirus-vector vaccine. Vaccine. 2024 Nov 14;42(25):126118. doi: 10.1016/j.vaccine.2024.07.019. Epub 2024 Jul 18. PubMed PMID: 39025696.
• Lee R, Park SY, Park JY, Kim B, Kim YC, Ga H, Lee MJ, Park HW, Yun IJ, Heo SJ, Moon SM, Kim HB. Evaluating antimicrobial utilization in 20 Korean long-term care hospitals: a call to action for antimicrobial stewardship. J Hosp Infect. 2024 Nov;153:65-72. doi: 10.1016/j.jhin.2024.08.005. Epub 2024 Aug 22. PubMed PMID: 39181451.
• Kim JA, Kim SH, Kim JJ, Noh H, Lee SB, Jeong H, Kim J, Jeon D, Seo JS, On D, Yoon S, Lee SG, Lee YW, Jang HJ, Park IH, Oh J, Seok SH, Lee YJ, Hong SM, An SH, Bae JY, Choi JA, Kim SY, Kim YB, Hwang JY, Lee HJ, Kim HB, Jeong DG, Song D, Song M, Park MS, Choi KS, Park JW, Yun JW, Shin JS, Lee HY, Kwon HK, Seo JY, Nam KT, Gee HY, Seong JK. Immune Cells Are Differentially Affected by SARS-CoV-2 Viral Loads in K18-hACE2 Mice. Immune Netw. 2024 Apr;24(2):e7. doi: 10.4110/in.2024.24.e7. eCollection 2024 Apr. PubMed PMID: 38725670; PubMed Central PMCID: PMC11076298.
• Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials. EClinicalMedicine. 2024 Mar;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. PubMed PMID: 38361992; PubMed Central PMCID: PMC10867612.
• Choi S, Lee J, Kim S, Lee YW, Kim GC, Hong SM, An SH, Noh H, Kim KE, On D, Lee SG, Jang HJ, Kim SH, Kim J, Seo JS, Kim JJ, Park IH, Oh J, Kim DJ, Yoon JH, Seok SH, Lee YJ, Kim SY, Kim YB, Hwang JY, Lee HJ, Kim HB, Park JW, Yun JW, Shin JS, Seo JY, Nam KT, Choi KS, Kwon HK, Lee HY, Kim JK, Seong JK. A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice. EBioMedicine. 2024 Jan;99:104932. doi: 10.1016/j.ebiom.2023.104932. Epub 2023 Dec 19. PubMed PMID: 38118400; PubMed Central PMCID: PMC10772566.
• Lim SY, Jo HJ, Lee SY, Ahn M, Kim Y, Jeon J, Kim ES, Chin B, Choi JP, Kim NJ. Clinical Features of Mpox Patients in Korea: A Multicenter Retrospective Study. J Korean Med Sci. 2024 Jan 29;39(4):e19. doi: 10.3346/jkms.2024.39.e19.
• Tran-The T, Heo E, Lim S, Suh Y, Heo KN, Lee EE, Lee HY, Kim ES, Lee JY, Jung SY. Development of machine learning algorithms for scaling-up antibiotic stewardship. Int J Med Inform. 2024 Jan;181:105300. doi: 10.1016/j.ijmedinf.2023.105300. Epub 2023 Nov 15. PMID: 37995386
• Oh TK, Song KH, Heo E, Song IA. Epidemiologic characteristics of people living with human immunodeficiency virus in South Korea: a nationwide cohort study. Sci Rep. 2024 Oct 17;14(1):24398. doi: 10.1038/s41598-024-76043-3. PMID: 39420078.
• Ryu J, Kim NH, Ohn JH, Lim Y, Lee J, Kim HW, Kim SW, Park HS, Kim ES, Yoon S, Heo E, Kim ES. Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia. Sci Rep. 2024 Sep 30;14(1):22669. doi: 10.1038/s41598-024-73304-z. PMID: 39349548
• Kim J, Myung R, Kim B, Kim J, Kim T, Lee MS, Kim UJ, Park DW, Kim YS, Lee CS, Kim ES, Lee SH, Chang HH, Lee SS, Park SY, Choi HJ, Kim HI, Ha YE, Wi YM, Choi S, Shin SY, Pai H. Incidence of Clostridioides difficile Infections in Republic of Korea: A Prospective Study With Active Surveillance vs. National Data From Health Insurance Review & Assessment Service. J Korean Med Sci. 2024 Apr 1;39(12):e118. doi: 10.3346/jkms.2024.39.e118. PMID: 38565175
• Kim SH, Kim SW, Kwon KT, Jeong HW, Peck KR, Kang ES, Koh JY, Ko JH, Yoon TH. Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profiling. Immun Ageing. 2024 Jul 30;21(1):51. doi: 10.1186/s12979-024-00454-z. PMID: 39080742
• Kim ET, Lee JH, Shim DJ, Kwon Y, Cho SB, Kim KJ, Kim D, Kim J, Kim ES, Jun H, Kim YJ, Kim J, Kim EJ, Kim CJ, Jun KI, Shin MJ, Yoon CJ, Lee S, Song SY, Won JH. Subcutaneous tunnelling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a multi-centre, open-label, randomized, controlled trial. J Hosp Infect. 2025 Jan;155:106-114. doi: 10.1016/j.jhin.2024.10.008. Epub 2024 Oct 26. PMID: 39490586
• Park JW, Park S, Lee E, Kim T, Kim ES, Kim B, Yoo SY, Han SH, Kim TH. Latent factors affecting safer injection practices that can reduce infections and how education can improve them. PLoS One. 2024 Oct 18;19(10):e0308567. doi: 10.1371/journal.pone.0308567. eCollection 2024. PMID: 39423176

류마티스내과

• Choi SR, Shin A, Ha YJ, Lee YJ, Lee EB, Lee ES, Kang EH. All-cause and cause-specific mortality in patients with Behçet disease versus the general population. 2024 May 17;190(6):858-866. doi:10.1093/bjd/ljae051.
• Choi SR, Lee JH, Kang EH, Lee YJ, Pyo JY, Park YB, Ahn MH, Kim HA, Ha YJ. Soluble programmed death-1 is a useful indicator for mortality in patients with adult-onset Still's disease. 2024 Jun;27(6):e15240. doi:10.1111/1756-185X.15240.
• Lee JI, Park JW, Jung Y, Shin K, Choi SR, Kang EH, Lee YJ, Yoo JJ, Ha YJ. Clinical characteristics and courses of Korean patients with giant cell arteritis: a multi-center retrospective study. 2024 Jul 1;31(3):160-170. doi: 10.4078/jrd.2024.0007. Epub 2024 May 14.
• Kim JH, Chung SW, Lee YJ. Corticosteroid-free adalimumab-cyclophosphamide combination therapy for acute phase neuro-Behçet's disease: a case report. 2024 Jul 1;31(3):178-181. doi: 10.4078/jrd.2023.0069.
• Shin A, Koo BK, Lee JY, Kang EH. Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study. 2024 Aug 28:386:e079475. doi: 10.1136/bmj-2024-079475.
• Shin JH, Pyo JY, Han M, Lee M, Lim SM, Baek JY, Lee JY, Kang JM, Jung I, Ahn JG. Incidence and disease burden of autoimmune inflammatory rheumatic diseases after non-pharmaceutical interventions in the COVID-19 era: A nationwide observational study in Korea. 2024 Apr;27(4):e15144. doi: 10.1111/1756-185X.15144.
• Ha YJ, Lee JI, Choi SR, Kang EH, Kim KS, Jeong WJ, Hyon JY, Kim MJ, Cha S, Lee YJ. Implications of thyroid-related autoantibodies in patients with Sjögren's syndrome without overt thyroid diseases. 2024 Dec;42(12):2404-2411. doi: 10.55563/clinexprheumatol/b3035x. Epub 2024 Nov 15.
• Kang EH, Shin A, Park CS, Lee EB, Lee YJ, Curhan G, Choi HK. Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study. 2024 Sep 1;63(9):2433-2441.
• Lee LE, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study. 2024 Jan;43(1):367-376. doi: 10.1007/s10067-023-06720-7.
• Ha JW, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria. 2024 Aug 20;34(5):1006-1012. doi: 10.1093/mr/road105.
• Yoon T, Ha JW, Pyo JY, Song JJ, Park YB, Ahn SS, Lee SW. Circulating cold-inducible RNA-binding protein levels in microscopic polyangiitis and granulomatosis with polyangiitis: Correlation with disease activity. 2024 Feb;83(Suppl 1):230-235. doi: 10.1007.
• Park J, Yang HK, Ha YJ, Hwang JM. Early Identification and Treatment of Sjögren Syndrome With Bilateral Tonic Pupils: A Case Report. 2024 Sep 1;44(3):e408-e409.
• Cho A, Ahn J, Kim A, Lee YJ, Song YW, Tanaka Y, Yi EC. A multi-biomarker panel for predicting Tocilizumab response in Rheumatoid arthritis patients. 2024 Nov;273:23-31. doi: 10.1016/j.trsl.2024.07.001. Epub 2024 Jul 6.
• Yoon T, Ha JW, Pyo JY, Ko E, Ahn SS, Song JJ, Park YB, Lee SW. Serum syndecan1 has the potential to reflect activity at diagnosis and predict death during follow-up in patients with ANCA-associated vasculitis. 2024 Sep 20;26(1):166. doi: 10.1186/s13075-024-03393-8.
• Ha YJ, Shin S, Choi SR, Kang EH, Song YW, Lee YJ. Poor prognostic factors independently impact remission and treatment escalation in rheumatoid arthritis regardless of disease activity: A nationwide prospective cohort study. 2024.105798. Epub 2024 Oct 24.

노인병내과

• Choi JY, Ryu DR, Lee HY, Lee JH, Hong Y, Park SK, Lee JH, Hwang SJ, Kim KH, Lee SH, Kim SY, Park JH, Kim SH, Kim HL, Choi JH, Kim CH, Cho MC, Kim KI. Association Between Orthostatic Hypertension and Frailty Among Older Patients With Hypertension. Hypertension. 2024 Jun;81(6):1383-1390. doi: 10.1161/HYPERTENSIONAHA.123.22382. Epub 2024 Mar 21. PMID: 38511313.
• Huh Y, Kim YJ, Choi JY, Lee JE, Jung HW, Shin CM, Won CW, Son KY. Comparison of anticholinergic burden with chronic polypharmacy on functional decline and mortality in Korean older people: a retrospective nationwide cohort study. BMC Geriatr. 2024 Jan 23;24(1):90. doi: 10.1186/s12877-024-04692-0. PMID: 38262951; PMCID: PMC10807110.
• Choi JY, Kim H, Chun S, Jung YI, Yoo S, Oh IH, Kim GS, Ko JY, Lim JY, Lee M, Lee J, Kim KI. Information technology-supported integrated health service for older adults in long-term care settings. BMC Med. 2024 May 29;22(1):212. doi: 10.1186/s12916-024-03427-7. PMID: 38807210; PMCID: PMC11134747.
• Suh Y, Jeong J, Park SM, Heo KN, Lee MY, Ah YM, Kim JW, Kim KI, Lee JY. Development of a claims-based risk-scoring model to predict emergency department visits in older patients receiving anti-neoplastic therapy. Sci Rep. 2024 Jan 17;14(1):1485. doi: 10.1038/s41598-024-51981-0. PMID: 38233529; PMCID: PMC10794170.
• Choi JY, Kim H, Chun S, Jung YI, Yoo S, Oh IH, Kim GS, Ko JY, Lim JY, Lee M, Lee J, Kim KI. Information technology-supported integrated health service for older adults in long-term care settings. BMC Med. 2024 May 29;22(1):212. doi: 10.1186/s12916-024-03427-7. PMID: 38807210; PMCID: PMC11134747.

종합내과

• Kim NH, Han K, Ji E, Ahn S, Choi Y, Choi SJ, Moon SM, Song KH, Kim ES, Kim HB. Trends of antibiotic use at the end-of-life of cancer and non-cancer decedents: a nationwide population-based longitudinal study (2006-2018). Antimicrob Steward Healthc Epidemiol. 2024 May 13;4(1):e83. doi: 10.1017/ash.2024.75. eCollection 2024. PMID: 38751939. Free PMC article.
• Lee JO, Lee S, Lee D, Hwang T, Joe S, Yang JO, Jeong J, Ohn JH, Kim JH. KTED: a comprehensive web-based database for transposable elements in the Korean genome. Bioinform Adv. 2024 Nov 19;4(1):vbae179.
• Jo H, Ahn S, Ohn JH, Shin CM, Ji E, Kim D, Jung SJ, Lee J. Insulin Resistance and Impaired Insulin Secretion Predict Incident Diabetes: A Statistical Matching Application to the Two Korean Nationwide, Population-Representative Cohorts. Endocrinol Metab (Seoul). 2024 Oct;39(5):711-721.
• Kim ES, Islam J, Lee HJ, Seong SY, Youn JI, Kwon BS, Kim SJ, Lee JH. Myeloid-derived suppressor cells in pleural effusion as a diagnostic marker for early discrimination of pulmonary tuberculosis from pneumonia. Front Immunol. 2024 Apr 29;15:1390327. doi: 10.3389/fimmu.2024.1390327. eCollection 2024.
• Ryu J, Kim NH, Ohn JH, Lim Y, Lee J, Kim HW, Kim SW, Park HS, Kim ES, Yoon S, Heo E, Kim ES. Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia. Sci Rep. 2024 Sep 30;14(1):22669. doi: 10.1038/s41598-024-73304-z.
• Song JE, Ji E, Kim NH, Ohn JH, Lim Y, Lee J, Kim HW, Kim SW, Ryu J, Park HS, Kim ES. Efficacy of an Aspiration Prevention Program That Utilizes the Gugging Swallowing Screen in Older Patients. Clin Interv Aging. 2024 Aug 22;19:1461-1470. doi: 10.2147/CIA.S474569. eCollection 2024.
• Hee Jin Kim, Nayoung Kim, Jae Young Jang, Sihyun Kim, Jongchan Lee, Hyeon Jeong Oh. Influence of cytokine genetic polymorphisms in Helicobacter pylori–associated gastric inflammation according to sex in South Korea. Gut Liver. 2024 Nov 15;18(6):1002-1013. doi: 10.5009/gnl230359. Epub 2024 Feb 23.
• Jiwon Ryu, Sejoong Kim, Yejee Lim, Jung Hun Ohn, Sun-Wook Kim, Jae Ho Cho, Hee Sun Park, Jongchan Lee, Eun Sun Kim, Nak-Hyun Kim, Ji Eun Song, Su Hwan Kim, Eui-Chang Suh, Doniyorjon Mukhtorov, Jung Hyun Park, Sung Kweon Kim, Hye Won Kim . Sodium intake estimation in hospital patients using AI-based imaging: prospective pilot study.  JMIR Formative Research, 8(1), e48690.
• Park, Y., Kim, S. H., Ryu, J., &Yoon, H. J. (2024). Association of midlife body-weight variability and cycles with earlier dementia onset: a nationwide cohort study. Alzheimer's Research &Therapy, 16(1), 91.
• Yi, J., Oh, Y. J., You, J., &Ryu, J. (2024). Air Quality and Kidney Health: Assessing the Effects of PM10, PM2. 5, CO, and NO2 on Kidney Function in Primary Glomerulonephritis. Journal of the American Society of Nephrology, 35(10S), 10-1681.
• Kim WY, Baek A, Kim Y, Suh Y, Lee E, Lee EE, Lee JY, Lee J, Park HS, Kim ES, Lim Y, Kim NH, Ohn JH, Kim SW, Ryu J, Kim HW. The Impact of Real-Time Documentation of In-Hospital Medication Changes on Preventing Undocumented Discrepancies at Discharge and Improving Physician-Pharmacist Communication: A Retrospective Cohort Study and Survey. J Multidiscip Healthc. 2024 Jun 25;17:2999-3010. doi: 10.2147/JMDH.S460877. eCollection 2024.PMID: 38948395 Free PMC article.
• Kim HJ, Kim J, Ohn JH, Kim NH. Economic evaluation of the hospitalist care model in an acute medical unit: a benefit-cost analysis. BMJ Open. 2024 Jul 29;14(7):e081594. doi: 10.1136/ bmjopen -2023-081594.PMID: 39079725 Free PMC article.
• Kim H, Seo JH, Nam JH, Lim Y, Choi KH, Kim K. Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study. Front Pharmacol. 2024 Oct 30;15:1443175. doi: 10.3389/fphar.2024.1443175. PMID: 39545068; PMCID: PMC11561712.
• Baek HS, Shin K, Kim J, Jeong C, Lee J, Lim Y, Baek KH, Ha J. Efficacy of a single 5 mg zoledronic acid infusion in preventing bone loss and fracture in postmenopausal women with breast cancer. J Bone Miner Metab. 2024 Nov;42(6):720-727. doi: 10.1007/s00774-024-01552-0. Epub 2024 Sep 30. PMID: 39349870.
• Lee J, Kim J, Jeong C, Ha J, Lim Y, Baek KH. Predicting fragility fractures based on frailty and bone mineral density among rural community-dwelling older adults. Eur J Endocrinol. 2024 Jul 2;191(1):75-86.
• Kim H, Choi CU, Rhew K, Park J, Lim Y, Kim MG, Kim K. Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis. Atherosclerosis. 2024 Apr;391:117490.
• Jung Won Lee, Nayoung Kim, Jongchan Lee, So Young Jo, Dong Ho Lee. Efficacy of Tegoprazan-Containing Sequential Eradication Treatment Compared to Esomeprazole- Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance:A Prospective, Randomized, Single Tertiary Center Study. Helicobacter. 2024 Sep-Oct;29(5):e13143. doi:10.1111/ hel.13143.
• Ho Soo Chun, George V Papatheodoridis, Minjong Lee, Hye Ah Lee, Yeong Hwa Kim, Seo Hyun Kim, Yun-Seo Oh, Su Jin Park, Jihye Kim, Han Ah Lee, Hwi Young Kim, Tae Hun Kim, Eileen L Yoon, Dae Won Jun, Sang Hoon Ahn, Vana Sypsa, Cihan Yurdaydin, Pietro Lampertico, Jose Luis Calleja, Harry LA Janssen, George N Dalekos , John Goulis, Thomas Berg, Maria Buti, Seung Up Kim, Yoon Jun Kim. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B. J Hepatol. 2024 Jan;80(1):20-30. doi: 10.1016/j.jhep.2023.09.011. Epub 2023 Sep 19.